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ABSTRACT 
During the past 20 years there has been a remarkable growth in the use of the 
fluorescence technique in biological studies. Fluorescence and time-resolved 
fluorescence spectroscopy are considered primary research tools in the field of 
biochemistry. Currently, fluorescence spectroscopy is a dominant methodology and used 
widely in biotechnology and medical diagnosis process. One impediment in using 
fluorescent probes is the fluorescence of biological substrates and fluorescence of 
diagnostic probes are significantly overlapped, and it decreases the detection sensitivity. 
Also, commercially available probes require UV or near-UV light excitation, causing 
severe degradation of biological substrates. Near-infrared emitting lanthanide complexes 
can overcome this problem by enhancing the detection sensitivity. 
BODIPY dyes have gained significant attention in application of fluorescence sensing 
and imaging in recent years, because they possess many desirable properties such as high 
extinction coefficient, narrow absorption and emission bands, high quantum yield and 
low photobleaching effect. One strategy to overcome the low detection sensitivity of 
fluorescent dyes is; shift the absorbance and emission of BODIPY precursor towards the 
longer wavelength regions by increasing the n-conjugation of a sensitizer. BODIPY 
molecules are especially responsive to this method.  
Four BODIPY-based ligands and four Yb(III) lanthanide complexes have been 
synthesized, which bear 5 -ethynyl-5 '-methyl-2,2'-N-bipyridine ligand-binding-group 
(LBG) in the C2 position and either a hydrogen (PH I ), an iodine (PH2), an 4-
ethynylbenzoic acid (PH3) or an 1 -ethynyl-4-isothiocyanatobenzene (PH4) groups in its 
vi i i  
C6 position. This study focused to test their ability to sensitize the luminescence of NIR 
emission of Yb(Ill) ion. All ligands exhibited broader absorption with high molar 
absorption coefficients. The PH3 ligand displays maximum absorption at (573 nm). The 
typical metal centered luminescence is detected at 980 nm for Yb(III) upon excitation at 
their maximal absorption position in the visible region. All complexes showed similar 
lifetimes in the NIR region ( 1 0 .9  - 1 1 . 1  µs), which corresponds to emission yield of 
0 .09%. This study demonstrates that the BODIPY-bipyridine ligands are adequate for 
sensitizing the luminescence of NIR-emitting lanthanide ions, allowing excitation 
wavelengths extending into the red region of the visible spectrum. 
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Chapter 1 
INTRODUCTION 
1.0 General Overview 
There has been an increasing demand for luminescence probes with a high sensitivity, 
low toxicity, and low cost. However, biological substrates have numerous fluorescent 
active groups. 1 The biological substrate fluorescence and diagnostic probes fluorescence 
are significantly overlapped. Therefore, it decreases the detection sensitivity. 2 The test 
sensitivity depends on the ratio of materials and background signals .  Also, commercial ly 
available probes cause some severe biological degradation due to the UV or near-UV 
light excitation.3 Near-infrared emitting organic complexes have overcome this problem. 
It also has the potential to enhance the detection sensitivity because biological substrates 
do not exhibit NIR emission. The NIR light luminescent probes can be used in in-vivo 
medical diagnosis process because of its deep tissue penetration capability. 4 Lanthanide 
ions such as Nd(III) , Yb(III) , Er(III) , Tm(III), Sm(III), Ho(III) , and Pr(III) emit in NIR 
region. NIR emission from lanthanide ions is difficult to obtain by direct excitation 
because of its weak f-f transition absorption. 5 To solve this problem, chromophores 
(antenna) are usually attached to lanthanide ions to form coordinated complexes. After 
absorption of UV light and intersystem crossing, the organic chromophore is excited 
from its ground state to its excited state. Then the energy transfers to the lanthanide 
excited state via an intramolecular energy transfer process. When lanthanide ion returns 
to its ground state, produces a characteristic NIR emission. A large number of lanthanide 
complexes have been studied. However, these complexes only emit under the UV or near 
1 
UV light illumination causing severe degradation and poor detection sensitivity.4-5 In this 
study, borondipyrromethene (BODIPY) was used as an organic chromophore to sensitize 
the ytterbium (III) ion, because of its excellent biocompatibility and stability for medical 
applications. 5 This study focused on Yb(III) ion since it has only one excited state and 
emits at 980 nm strongly. These complexes were found to be sensitized under long 
wavelength region. 
1.1 Phenomena of Fluorescence 
Fluorescence phenomenon was reported by Sir John Frederick William Herschel. He 
observed fluorescence from a quinine solution under the sunlight in 1 845 . The 
development of the first spectrofluorometer appeared in 1 950 with the rapid development 
of fluorescence technology. Luminescence can be categorized into two forms: 
fluorescence and phosphorescence, which are determined by the nature of the excited 
state of the compound.6,7 The molecules which have fluorescent properties are known as 
fluorophores, and typically they are aromatic compounds (pyrene, quinine, anthracene ) .  
Fluorescence spectra are depended upon the chemical structure of  the fluorophore and 
dissolved solvent. 1 
The principles of the absorption and emission are usually illustrated by the Jablonski 
diagram, which was introduced by Alexander Jablonski . 1 Jablonski is regarded as the 
father of spectroscopy because of his many achievements in the fluorescence 
spectroscopic field. The energy levels SO, S 1 ,  and S2, are depicted by singlet ground, first 
and second electronic states, respectively. Several processes usually occur under the light 
irradiation. The fluorophores are excited to higher vibrational levels, either S 1 or S2.  
Then the molecules rapidly relax to the lowest vibrational level of S 1 (Figure 1 .0) . The 
2 
process of internal conversion happens within 10-12 s or less that is smaller than the 
fluorescence lifetimes 1 o-s s. 8 So this internal conversion process usually completes prior 
to the fluorescence. The fluorophores in the lowest vibrational state of S 1 return to an 
excited vibrational state at the level of the SO, releasing the energy through emission of 
photons.  This process is known as fluorescence. As a consequence of emission to an 
excited vibrational state of SO, the emission spectrum acts as a mirror image of an 
absorption spectrum of the SO to S 1 transition. 1•9 The fluorophores in the excited state of 
S 1 transfer to the triplet state Tl via intersystem crossing process between different spin 
states .  The transition process from the Tl to the SO state is known as phosphorescence, 
and it has long wavelength emission relative to the fluorescence due to the lower energy 
level of Tl relative to the S 1 state. As a consequence of this, the emission rate of 
phosphorescence is smaller than that of fluorescence. 10 
\,,. Internal conversion 
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Figure 1.0 One form of a Jablonski diagram : SO; ground state, S l ,  S2; excited state, T l ;  triplet 
state 
3 
1.2 Characteristics of Fluorescence 
1 .2 . 1  Representation of fluorescence data 
Fluorescence data is typically shown as an emission and excitation spectra. The plot is 
shown as the fluorescence intensity vs wavelength (nm). The intensity and the shape of 
the fluorescence spectrum depends on the chemical structure, solvent, excited states and 
other factors. 1 The symmetric nature of this excitation and emission exhibits the same 
transitions in both absorption and emission and also the similar vibrational energy levels 
So and S1 . 
1 .2.2 Stokes shift 
The Jablonski diagram explains that the energy of emission is always less than the 
absorption. This reduction is because of the longer wavelength of emission than the 
absorption (Figure 1 .2) .  In 1 852, Sir G. G. Stokes discovered wavelength shift known as 
the "Stokes shift." The Stoke shift causes further loss of excitation energy by 
thermalization of excess vibrational energy. The rapid decay to the lowest vibrational 
level of S 1 and decay to the lowest vibrational level of SO affect the energy loss process. 
The typical fluorescence spectrum has a broad emission spectrum with mirror image 
absorption spectrum of SO - S 1 transitions. Fluorescence displays a smaller Stokes shift 
than the phosphorescence because triplet energy level is lower than the singlet level 













Figure 1.2 Stokes shift12 
1 .3 Applications of Fluorescence 
Fluorescence sensing and imaging technology have been growing in various fields of 
modem science during the past 20 years. This technology has become a very powerful 
and essential tool in the area of biotechnology, molecular biology, environmental science 
and clinical diagnostic . This method is more important compared to the traditional 
methods like electrochemical detection, chemo-absorptive detections, NMR and radio 
tracing in chemical recognition events, especially for biological sensing and imaging 
analysis .  The biological sensors are an analytical device, used for the detection of an 
analyte that combines a biological component with a physicochemical 
detector. The sensitive biological elements like tissue, microorganisms, organelles, cell 
receptors, enzymes, antibodies and nucleic acid are biologically derived material or 
biomimetic component that interacts with the analyte under study. 1, 12 
5 
1 .3. 1 Fluorescence sensing and fluorescence probes 
Fluorescence sensing is an ideal technology for the biological diagnostic non-invasive 
processes with ultra-high sensitivity and specificity. It does not consume or destruct 
analytes surrounding objectives . 1 3 Also, it has a rapid response time ( 1 0-8 s), and 
fluorescence travel without a physical guide as a reference material, which extensively 
simplifies this technique with low costs . 1 Fluorescence sensing technology has become 
the most important technique for diagnosis and screening purposes in the medical field. 1 4 
Fluorescent probe is a key component of fluorescence sensing technology because it has 
some ability to convert chemical events to detectable fluorescent signals. It is also 
correlated with sensitivity, specificity and response range. 
The fluorescence sensing and imaging are dependent on the desired properties of 
fluorescent probes. The designed fluorescent probes should have an ability to respond 
selectively and specifically to the analyte of interest without any interference. 8 Brightness 
of the fluorescence should be sharp as possible because it can obtain high quantum yield 
and large extinction coefficient at the excitation wavelength. Also, the chemo stability 
and the photostability of the fluorescent probes should be at a high level. Most of the 
properties in fluorescent probes suffer from photobleaching due to the instability. 1 1  
Application of the fluorescent probes inside of living cells or biological tissues is a much 
more complicated process. Therefore, these probes should have some features to give a 
proper outcome in the biological sensing and imaging diagnosis process. The size of the 
fluorescent dyes should be suitable to allow its insertion into the biological system, and 
the typical size range is from 0 .5 -2 .0  nm . Molar absorptivity of these dyes is around 1 03 -
1 05 M-1 cm-1 and Stokes shift i s  short and typically ranges from 1 0- 1 00 nm . The 
6 
maximum excitation wavelength depends on the chemical structure of the fluorescent 
dyes and spectroscopic techniques being used. 1 5  
The biological sensing and labeling molecular fluorescent dyes have unique absorption 
and emission properties relative to the radioactive labeling and electrochemical sensing 
absorbance based dyes. These chromophores are much more sensitive, non-invasive and 
more informative compared to the other dyes. Nowadays, scientists have synthesized 
different types of chromophores that absorb and emit in the visible to near infrared 
regions . The most important chromophore families are rhodamines, cyanines, fluorescein 
and BODIPY. 1 5 
1.4 BODIPY dyes 
BODIPY dyes have many advantages compared with the other three fluorescent 
chromophores mention above. Boron dipyrromethene (BODIPY) dyes are good 
candidates because of their excellent spectroscopic and chemical properties such as high 
molar extinction coefficient, high fluorescence quantum yields, excellent photostability, 
coupled with chemical versatility, color tunability, moderate redox potential, and 
negligible sensitivity to solvent and temperature. In this research, BODIPY was used as 
the main skeleton fluorophore to synthesize new BODIPY ligands. 1 5 • 1 6, 1 7 
In 1 968,  Triebs and Kreuzer first investigated the fluorescent active BODIPY dyes by 
reacting pyrrole and acetic anhydride . IUPAC name of BODIPY is 4,4-Difluoro-4-bora-
3a,4a-diaza-s-indacene. The BODIPY core is formed by linking dipyrromethene ligand 
through the N-B-N bridge. It delocalized the positive charge via resonance equilibrium. 
According to the X-ray diffraction single crystal structure, BODIPY core has a fused 
7 
planar twelve member framework, and two fluorine atoms are bound to the boron atom 
leading to a tetrahedral geometry. 1 8 According to the IUPAC numbering system, 
BODIPY core has eight functional positions and these also label as a-, �- and meso-
positions (Figure 1 .3 ) .  The substituted BODIPY dyes are easier to synthesize than 
unsubstituted dyes because of high stability. Particularly, the hydrogen atoms at the a-
positions of the pyrrole ring are substituted by two methyl groups to prevent further 
electrophilic substitution. The BODIPY dyes can be functionalized using different types 
of reactions like electrophilic substitution at 2 ,  6- positions, condensation reactions at 3 , 5  
or  2 ,6  positions, or  nucleophilic substitution at 3 , 5  or  4 or  8 positions . 1 5 Researchers have 
been modifying these n-conjugated molecules for biological sensing and imaging 
applications . However, they are facing many challenges because of the undesirable 
characteristics of BODIPY dyes like hydrophobicity, lack of efficient sensing for toxic 
species and intracellular pH and transition metal ions. Additionally, the short wavelength 
absorption and emission cause biological degradation to the tissues. To overcome the 
problem of low sensitivity and biological degradation, researchers have synthesized NIR-
emissive BODIPY-lanthanide fluorescent probes for biological sensing and imaging 
applications. 24 
Figure 1.3 Structure of BODIPY core and numbering system 
8 
1 .4 .1  Synthesis of BODIPY dyes 
BODIPY dyes can be synthesized using a one pot method via the condensation reaction 
of pyrrole and aldehyde, acid chloride or acid anhydride. The reaction produces two 
intermediates :  dipyrrolmethane and dipyrrin. DDQ (2,3 -dichloro-5 ,6-dicyano- 1 ,4-
benzoquinone) is used as an oxidant to synthesize dipyrrin from dipyrrolmethane to 
synthesize BODIPY using aldehydes (Figure 1 .4). Then boron trifluoride diethyl etherate 
(BF3•EtiO) is added to the reaction mixture under basic conditions to synthesize a 
fluorescent active BODIPY. 1 5, 23, 24 
DDQ Base 
.. 
Figure 1.4 Synthetic route of BODIPY dyes using aromatic aldehyde 
1 .4.2 Modification of BODIPY core 
The properties of the BODIPY dye can be altered by modifying the BODIPY core . There 
are four main positions in the BODIPY core, 3 ,  2 ,  8 carbon centers, and 4 boron center. 
These active positions can be modified by attaching different types of organic fragments 
to its core structure . 1 5  
1.4.2.JFunctionalization at the 2,6-positions of BOD/PY core 
A simple examination of the structure (Figure 1 . 5)  reveals that the least positive charge is 
at the 2- and 6- positions if BODIPY core . This electron rich 2 and 6 positions facilitate 
the electrophilic substitution reaction like halogenation, formylation, nitration and 
9 
sulfonation. The halogenation reaction can undergo iodination reaction by slowly adding 
a iodine source (NIS) to the BODIPY reaction mixture (Figure 1 .6) . 1 9 In this research, 
iodination reaction was used for the purpose of further modification of BODIPY core. 
The 1t- conjugation between the iodine and BODIPY core increases the Aabs and A.em with 
20-50 nm from initial BODIPY molecule absorption. 
- -
Figure 1.5 Resonance structures of BODIPY core 
NIS 
Figure 1.6 Iodination of BODIPY dyes 
Quantum yield of the dyes is decreased due to the intersystem crossing of electrons from 
the excited state to the triplet state of the BODIPY dye because of the "heavy atom" 
effect from iodine atom.20•2 1 Halogenated BODIPY dyes are good starting materials in the 
synthesis of long conjugated systems through various carbon-carbon cross coupling 






x x Pd0, base Ar Ar 
Heck coupling 
X= I or Br 
Figure 1.7 Cross-coupling reactions of 2,6- position of BODIPY core 
1.4.2.2 Sonogashira coupling reaction 
The Sonogashira coupling reaction is one of the most useful cross-coupling methods to 
form conjugated enynes or aryl alkynes using C-C and C-heteroatom bonds.22 The 
reaction is based on a palladium compound used as a catalyst and Cul as a co-catalyst 
(Figure 1 .8) . The active palladium catalyst reacts with a halogenated molecule in an 
oxidative addition step to produce a Pd11 intermediate, complex A. The formed complex 
A undergoes a transmetallation step with the copper acetylide and form out complex B .  
The Cul i s  allowed to form the conjugated enynes and aryl alkynes by pairing with a 
palladium catalyst.23,24 Complex B is changed from trans to cis to produce complex C .  In 
1 1  
the final step, complex C undergoes a reductive elimination process and generates the 
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Figure 1.8 Mechanism of Sonogashira cross-coupling reaction 
1 .5 Lanthanide Luminescence 
Lanthanide metals are part of the f-block elements and have [Xe]4.f5s25p6 electronic 
configuration. The lanthanide luminescence originates from f-f transitions in the 4.f 
shell .25• 26 There are some factors that limit the luminescence at the lanthanide ions . First, 
the 4f electrons of lanthanide ions are properly shielded from 5s and 5p orbitals by 
preventing the direct participation in chemical bonding. Absorption and emission spectra 
show narrow and sharp bands with a low molar absorption coefficient due to the 
12 
shielding effect from 5s and 5p electrons27 (Figure 1 .9) . Lanthanide compounds generate 
weak luminescence because of the low extinction coefficient. Second, f-f transitions of 
lanthanide ions are forbidden by spin and the Laporte rule, which affects the long excited 
state lifetime from millisecond to the microsecond. 28 Also it provides time-gated or time­
resolved in vivo medical applications. 4The direct excitation of lanthanide ions is 
inefficient because of the poor absorption capability of lanthanide ions. Therefore, a 
strong light source such as laser light has to be used. To enhance the efficiency of the 
lanthanide luminescence, researchers have introduced an organic molecules as ligands to 
obtain highly efficient NIR emission. 34,3 7  In 1940, Weissman introduced sensitized 
lanthanide luminescence complexes of terbium and samarium metals .  29,3o 
Er 
800 900 1000 1100 1200 1300 1400 1500 1600 
'A/nm 
Figure 1.9 Characteristic lanthanide emission peaks for Yb(III), Nd(III), Er(III). 
Reproduced with permission from ref 3 0. Copyright 2010 American Chemical Society. 
The principle behind the lanthanide probe is known as the antenna effect. The fragment 
that absorbs the light is called an antenna, and the energy transfer process occurs from the 
ligand to the lanthanide ions. 3o,34,3 8  First, the antenna ligand is excited to the singlet 
excited state (S 1 ) from the ground state (So) using absorbed energy, and secondly, the 
excited state energy transfers to the triplet state (T 1 ) through intersystem crossing (ISC). 
13 
If the lanthanide excited state is close enough to the T 1 state with lower energy, the triplet 










Figure 1.10 (A) Schematic diagram of lanthanide sensitization from organic chromophore. 
(B)Proposed energy diagram for sensitization process in Ln(III) complexes : SO; ground state, S I ; 
excited state, T; triplet state, Ln3+; lanthanide excited state, FL; fluorescence, PL; 
phosphorescence, ET; energy transfer 
1 .5. 1 Lanthanide luminescence efficiency 
The efficiency of the lanthanide luminescence process can be compromised by 
fluorescence from a singlet excited state, phosphorescence from triplet state and non-
radiative energy loss in either state. 32 If the energy level of the triplet state is lower than 
the lanthanide excited state, the energy transfer from the triplet state to lanthanide excited 
14 
state cannot occur.33 The coordination of water molecules reduces the excited state 
lifetime of lanthanide ions by non-radiative energy transfer to the high-frequency 0-H 
vibrational level. The Quantum yield of the lanthanide probes decrease with the number 
of water molecules.34 
The selection of lanthanide metals depends on several factors like emission wavelength, 
luminescence intensity and excited state lifetime of lanthanide ions . Among the 
lanthanide metals, the Gd(III) ion has the most luminescence, though it emits around 3 1 0  
nm . Therefore, Gd(III) lanthanide probes are not suitable for biological applications . The 
most often used lanthanide ions in biological sensitization are Tb(III) , Eu(III) , Sm(llI), 
Dy(III) and Tm(llI) (visible region) and Nd(III) , Yb(III) , Er(III) and Ho(III) (near 
infrared region) because of the excited states that exist very close to the ligand triplet 
state with lower energy. These ions can be excited using a wide variety of antenna 
ligands.34•32 In this study, Yb(III) lanthanide metal ion was mainly focused as a metal 
center of the synthesized ligands. Yb(III) ion emits around 980 nm which is related to 
2Fs12 -- 2F112 transition and has the highest emission intensity. 
1 .5.2 Lanthanide complexes 
During the last few decades, researchers have been working with different types of 
chromophores including P-diketonates,34,35 porphyrins,36,37 terphenyl ligands, 8-
hydroxyquinoline, 3s,39 pyrazolones, 1 ,4, 7,  1 0-tetraazacyclododecane, ferrocene, transition 
metal complexes and BODIPY. These probes have variable NIR emission efficiencies 
with different excitation wavelengths . 1 6 The metal complexes that explained below have 
short excitation wavelength when compare with the synthesized compounds in this study. 
15 
However, these metal complexes have efficient NIR emission with the long conjugated 
system. 
1.5.2.1  Porphyrin based lanthanide complexes 
Porphyrins are highly conjugated macrocyclic molecules which are chemically and 
thermally stable. They are mostly used in photodynamic therapy treatments because of 
the high absorption in the UV-Vis region. Porphyrins are easy to synthesize and can 
coordinate to a wide range of metal ions, to obtain variable porphyrin derivatives for 
different purposes. Porphyrin has a favorable triplet state energy level ( 1 5000 cm-1 ) to 
sensitize lanthanide metal ions . These features provide suitable electronic and optical 
properties to porphyrin complexes. Lanthanide porphyrins are mostly used in laser 
systems, sensing of biological substrates, molecular information storage, magnetic 
resonance shift reagents and so on.37•40 
The first lanthanide (III) monoporphyrinate complexes were reported in 1 974.4 1 Since 
then only a few studies have reported in the literature . In 200 1 ,  Wong and coworkers 
have reported neutral 3 d-4f bi-metallic porphyrinate complexes via the interaction of 
cationic lanthanide (III) (Er(III) and Yb(III)) porphyrinate complexes with sodium 
( cyclopentadienyl)-tris( diethylphosphito )cobaltate (Figure 1 . 1 1 ) .  They have observed 
almost identical UV-Vis absorption (60 1 nm) and emission at 1 53 1  nm for Er(III) 
complex and 92 1 nm for Yb(III) complex. The authors concluded that cationic Ln(III) 
porphyrinate complexes were good precursors for the preparation of neutral 3d-4f bi­
metallic porphyrinate complexes. Also, the porphyrinate ligand efficiently sensitized the 
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Figure 1.11 (a) NIR luminescence spectra of complex 1 (_ _ _) and 5 (--) in CHChupon 
excitation at 600 nm. (b) Room temperature absorption (--) spectrum and excitation (_ _ _  )
spectrum (monitored at 921 nm) of complex 5 in CHCh. Reproduced with permission from ref 
41. Copyright 200 1 Royal Society of Chemistry. 
In 2003 , Wong et al . prepared an unsymmetrical diethyl malonate appended porphyrin 
ligand and its lanthanide complexes (Yb(III), Er(III) , Nd(III)) (Figure 1 . 1 2) .  The 
photophysical properties of compounds are summarized in Table 1 . 1 .  The absorption 
bands at 422,552 and 5 89 nm and UV-Vis absorption of complexes were almost identical 
to each other (650 nm) . Quantum efficiency of the metalloporphyrin was much lower 
than that of the appended porphyrin free base ligand (0em = 3 . 56x 1 0-2) .  The NIR 
emission of Yb(III) and Er(III) peaks were centered at 980 nm and 1 544 nm, respectively. 
For Nd(III), the emission peak was centered at 853 nm and 890 nm (Figure 1 . 1 2) .  The 
17 
authors concluded that the porphyrin ring transferred the absorbed light to the lanthanide 
metal ions, to generate near-infrared emission of lanthanide ions. Also, they concluded 
that better donating solvents (DMF) could enhance the luminescence efficiency by 
replacing the coordinated water molecule (Figure 1 . 1 3  ). 42 
Table 1.1 Photophysical data of compounds a, b and c42 
Compound Absorption: Amax/nm Excitation: Aexlnm 
(a) 422, 552, 589 422 
(b) 422, 55 1 , 589 422 
(c) 422, 55 1 , 594 422 
OEt 0.000035 
Ln 
(a) Yb3+ 0.000030 � 
(b) Er3+ 
(c) Nd3+ 0 .000025 :::i 






Emission: A.em/nm (r, 0em x 1 03) 
650 (5 . 1  ns,0. 1 5) ,  980 (2 .43 µs) 
650 (3 .3  ns, 0 .098), 1 544 
650 (8 .9 ns, 5 . 02), 853 
� 
I \ 
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Figure 1.12 NIR luminescence spectrum (-) and excitation spectrum (- - -), monitored at 980 
nm, of complex (a) in CHCh. Reproduced with permission from ref 42 . Copyright 2003 Royal 
Society of Chemistry. 
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Figure 1.13 Photoluminescence of complex (a) in different solvents at room temperature. 
Reproduced with permission from ref 42 . Copyright 2003 Royal Society of Chemistry. 
In 2009, He research group synthesized several seven and eight coordinated ytterbium 
(III) tetraphenylporphyrinate complexes with diimines as ancillary ligands (Figure 1 . 1 4 ) .  
They observed a Soret band at about 430 nm, and Q bands centered on 550  nm and 600 
nm for porphyrinate ytterbium (III) complexesd-h. These results also agreed with the 
Gourterman' s  four-orbital model . They observed significant lower quantum efficiency (0 
= <0.005) for the Yb(III) complexes than the 5 , 1 0, 1 5 ,20-tetraphenylporphyrin ligand (0 
= 0 . 1 1 ), indicating the efficiency of intersystem crossing energy transfer to its triplet 
state . The NIR emission of seven-coordinate Yb(III) complexes ( d and h) was around 975 
nm with three shoulders at 950 nm, 1 000 nm, and 1 025 nm, and eight-coordinate 
complexes (2-5) were emitted around 975 nm and 1 005 nm with 946 nm shoulder peak 
(Figure 1 . 1 4) .43 
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Figure 1 .14 (a)Ytterbium (III) monoporphyrinate complexes (b)Visible (black) and NIR (red) 
emission of ytterbium complex e in toluene solution at room temperature (A.ex =375 nm). 
Reproduced with permission from ref 43 . Copyright 2003 Royal Society of Chemistry. 
1.5.1.2 8-hydroxyquinoline based lanthanide complexes 
8-Hydroxyquinoline (8-HOQ) and its halogenated derivatives can act as bidentate 
ligands. These ligands form metal complexes with lanthanide metals because of their 
excellent coordination properties. In 1 936 ,  Pirtea reported the first lanthanide 
20 
hydroxyquinoline complex. The hydroxyquinoline based ligands are used in the 
formation of metal complexes, not only because of their good coordination properties but 
also due to their of its useful photophysical properties. The triplet excited state of 8 -
hydroxyquinoline is located around 1 7 1 00 cm-1 and increases the intramolecular energy 
transfer efficiency in metal complexes.  The luminescence characteristics were 
investigated by H. Suzuki using different Er(Ill) hydroxyquinoline complexes .44 They 
have synthesized a wide variety of hydroxyquinoline lanthanide complexes by using 
different binding chromophores.  Antonio and co-workers have described the synthesis of 
the hydroxyquinoline based macrocyclic ligand using 8-hydroxyquinoline residue with 
Eu(III) and Er(III) lanthanide ions . The Eu(III) complex was exhibited an absorption 
around 268 nm and the photoluminescence emission of europium was displayed between 
590 -700 nm (Figure 1 . 1 5) .The Er(III) complex showed an emission at 1 530  nm arising 
from 411 312 -411 s12 transitions. Both complexes Eu(III) and Er(III) displayed high stability 
with strong sensitization emission under UV radiation, even in aqueous solution or water­
containing solvents . Moreover, the authors correlated the energy transfer ability from the 
sensitizer to the lanthanide ion with pH behavior of the antenna. This study revealed that 
the good solubility and sensitized emission in different solvents like organic and water 
are very important aspects of their technologic applications as NIR-emitting devices or 
luminescent probes.39 
2 1  
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Figure 1.15 (a) 8-hydroxyquinoline Eu(III) complex, (b) Absorption (dashed line), excitation 
( . . . . . . . ) and emission ( -) spectra for Eu(IIl)complex. Reproduced with permission from ref 42. 
Copyright 2009 Elsevier. 
J.5.l.3P-Diketonate based lanthanide complexes 
Among the lanthanide sensitization chromophores, J3-diketonatesare the most popular and 
the most investigated compounds since the 1 9th century. In 1 897, Urbain synthesized the 
first rare-earth J3-diketonates by using lanthanum(III) , Yttrium(III) and gadolinium(III) 
metal ions .45 J3-Diketonate rare-earth coordination complexes are used for different 
purposes, such as electroluminescence materials in organic light emitting diodes, 
catalysts in organic reactions, volatile reagents for chemical vapor deposition and as 
biological sensing materials .  The substitute groups on J3-diketonate can be substituted by 
the tertbutyl group to increase the solubility in organic solvents, by aromatic substituents 
to increase the light absorption and by perfluorinated alkyl groups to increase the Lewis 
acidity.34 
22 
�-Diketonate rare-earth complexes can be categorized into three main types : ternary rare­
earth �-diketonates complexes, tris complexes, and tetrakis complexes. Ternary rare-earth 
complexes contain Lewis base adducts besides the �-diketonate ligand because it 
facilitates the expanding of the coordination sphere and increases the coordination 
number (typically eight or nine) .  The Lewis acidic lanthanide ions preferentially make 
complexes with Lewis bases having oxygen-donor or nitrogen-donor groups. 1 ,  1 0-
phonanthroline derivatives and 2.2 '-bipyridine derivatives are mostly used as N-donor 
ligands. These types of �-diketonate complexes exhibit strong luminescence because of 
the better energy transfer in the rigid planar structure .46.47•49 
In 2008, Bilnzli and coworkers synthesized lanthanide complexes using a 1 ,3 -diketonato 
ligand by incorporating both electron donor and acceptor groups into the ligand. The 
maximum absorption for synthesized HL ligand was around 339  nm and 442 nm . The 
lower energy band at 442 nm was assigned to an intra-ligand charge transfer. Also, they 
observed a characteristic line-like infrared emission for Yb(III), Nd(III) , and Er(III) 
diketonate complexes due to f-f transition upon excitation in ligand absorption bands 
(Figure 1 . 1 6) .  The main advantage of the ligand HL is its lowest-energy absorption 
transition which extends into the visible range and allows excitation of lanthanide 
luminescence with wavelengths up to 550 nm . The overall luminescence efficiency of the 
Yb(III) complex, is 26 M-1 cm-1 at 428 nm (absorption maximum in the visible range) , 
5 .2 M-1 cm-1 at 500 nm, and 0 .4 M-1 cm-1 at 550 nm . According to the observed results, 
they concluded out that the push-pull 1 ,3 -diketonato ligands are suitable for visible light 
excitation of NIR emitting lanthanide ions . This study has obtained long excitation and 
emission wavelengths with long conjugated system using �-diketonate ligand.48 
23 
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Figure 1.16 (a) Structures of 1,3 -diketone l igands and lanthanide complex with HL ligand. (b) 
Absorption spectra of the l igand HL and the complex [Yb(HL)3phen] in DMSO solution . 
Reproduced with permission from ref 48 .  Copyright 2008 John Wiley and Sons. 
1.5.1.4  BOD/PY based lanthanide complexes 
The BODIPY dyes for the sensitization of lanthanide ions were only studied as antenna 
groups recently. The BODIPY dyes are used as chromophore because they have a high 
absorption coefficient, tunable spectral coverage, and chemical and photochemical 
resistance. Studies related to the NIR emission of BODIPY-lanthanide complexes are 
scarce because of the non-coordination ability of BODIPY core .37 In 2006, Bunzil and co-
24 
workers synthesized the first BODIPY lanthanide metal complex using terpyridine and 
BODIPY. Terpyridine was used as a ligand binding group and synthesized BODIPY­
terpyridyl ligand and related complexes [Ln(L)-(N03)3] (L=4,4-difluoro-8-(2 ' :2" ;6" :2" '­
terpyridin-4"-yl)- 1 ,3 , 5 ,  7-tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene 
(Boditerpy) Ln = (Yb(III), Nd(III) , Er(III), Gd(III), La(III)) . They observed NIR bands in 
the spectral range of 1 298- 1 428 nm, and 1 030- 1 086nm for [Nd(L)(N03)3] lanthanide 
complex. The NIR emission of Yb3+ complexes ([Yb(L)(N03)3] )  exhibited several peaks 
in the range 943 - 1 075 cm-1 which corresponds to the 2Fs12 � 2F712 transition (Figure 
1 . 1 7) .  The NIR emission efficiencies of Yb(III) and Nd(III) complexes were 0 .3 1 % and 
0 .0 1 6%, respectively. They also observed a very weak luminescence for the [Er(L)(N03)3 
complex under the same conditions. The authors reported that the quantum yield of the 
ligand decreased from 79% to 1 5 - 1 9% with the lanthanide complex formation. Moreover, 
authors revealed that the sensitization process, is mainly achieved by perturbation of 
excited states of BODIPY core by lanthanide coordination, and it leads efficient energy 
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Figure 1.17 Emission spectra of the [Yb(L)(NQ3)3] complex at 10 and 295 K (A.ex= l 9  455 cm-1 ) ;  
solid line : powdered sample, dotted l ine : single crystals. Reproduced with permission from ref 49.  
Copyright 2006 John Wiley and Sons. 
In 20 1 2, Bunzil and Ruy synthesized a benzoic acid functionalized BODIPY dye which 
formed terpyridine coordinated two lanthanide complexes which bear either hydrogen or 
bromine in the 2,6 positions (Figure 1 . 18) . 5 1  The emission intensity of the lanthanide 
complex was decreased in the visible range due to the introduction of a Br atom to the 
BODIPY ligand. The NIR emission of the Yb3+ complex was observed at 978 nm and 
Er3+ complex at 1 530  nm . They observed that the bromination enhanced the NIR 
emission intensity compared with the unbrominated complex. After bromination, the 
quantum yield of the ligands dropped from 3 1  % to 2 1  %. The authors ' concluded that the 
BODIPY molecule could efficiently sensitize the lanthanide ions, under the long 
wavelengths excitation with large molar absorption coefficients (logs � 5 .0-5 .2). They 
also revealed the importance of conformation of the chromophores on the yield of 
intersystem crossing. 50 
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Figure 1.18 (a) [Ln(L;)3(tpy)] lanthanide complex. (b) Metal-centered NIR emission of ErLi and 
YbLi with the concentration of 1 x 10-5 M in THF at room temperature A.ex = 5 83 nm: Li= 
hydrogen (L I )  or bromine (L2) l igands. Reproduced with permission from ref 50 .  Copyright 2012 
Royal Society of Chemistry. 
In 20 1 1 ,  He and co-workers synthesized a BODIPY functionalized 8 -hydroxyquinoline 
ligand for sensitization of lanthanide ions (Yb(III), Er(III), Nd(III)) . 1 6  The ligand formed 
stable lanthanide complexes with Ln(III) ions with 1 :3 metal to ligand molar ratio .  The 
ligand exhibited a strong absorption at 506 nm and an emission at 5 1 0  nm in organic 
solvents with 0.45 quantum yields in dichloromethane and 0 .005 in DMF. The lanthanide 
complexes Nd(III) and Er(III) have weak NIR emission at 1 060 nm and 1 3 82 nm, 
respectively. They observed a high emission for Yb(III) complex at 976 and 1 003 nm 
(Figure 1 . 1 9) .  The authors also demonstrated that the BODIPY moieties are efficient 
visible light sensitizers for lanthanide NIR emitters . 1 6  
2 7  
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Figure 1 .19  8-HOQ-BODIPY based lanthanide complex Emission spectra of the Yb3+, Nd3+and 
Er3+ complexes in CH2Cb.  The excitation wavelength was 522 nm. Reproduced with permission 
from ref 16. Copyright 2011 Royal Society of Chemistry. 
In 20 1 1 ,  He et al modified 8-HOQ-BODIPY ligand to 8-HOQ-BODIPY-31 ligand and 
achieved efficient NIR emission with strong longer wavelength absorption. 52 This ligand 
sensitized the Yb(III) ion efficiently under excitation at 540 nm . This was the first Yb(III) 
complex that emits NIR emission at a longer wavelength. Also, they observed that the 
fluorescence quantum yield decreased to 0 .00075 in DCM and to 0 .0026 in ethanol due to 
the efficient intersystem crossing of energy from singlet excited state to the triplet state . 
The NIR emission of Yb(III) complex was observed at 975 nm and one broad peak 
centered at 1 000 nm corresponding to the 2F 512 --+2F m2transition (Figure 1 .20). The 
lifetime of the iodinated lanthanide complex (�95± 1 7  µs) was much longer than the non-
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Figure 1 .20 Emission of [Yb(8-HOQ-BODIPY-31)3] in CH2Ch at room temperature. The 
excitation wavelength is 543 nm. The inset is the decay curve monitored at 975 nm under 
excitation at 375  nm and its single exponential fitting. Reproduced with permission from ref 42. 
Copyright 2011 Royal Society of Chemistry. 
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1 .6 Motivation 
There has been an increasing demand for fluorescent materials because of their potential 
application in material diagnostic tests such as immunoassays. Most of the commercially 
available probes need UV or near-UV wavelength for excitation, which causes severe 
photobleaching of bio-substrates. Besides, the significant overlap of biological 
autofluorescence and the fluorescence from commercial optical probes dramatically 
decreases the detection sensitivity. Therefore, it is imperative to investigate novel 
fluorescent materials for visualization of biological substrates. The fluorescent dyes that 
have been synthesized so far, emitted in the NIR region under UV excitation. However, 
dyes with a x-conjugation should efficiently emit in the NIR region under long 
wavelength excitation and therefore can be used in widespread applications in non­
invasive and in vivo fluorescence imaging. NIR probes will also eliminate background 
signals and increase detection sensitivity, since biological substrates do not exhibit NIR 
emission. In order to overcome these current problems, there is a need to design and 
synthesize lanthanide complexes that can be sensitized using the red light with strong 
emission in the NIR region. Following these previous studies, in this study, was focused 
to synthesize a ligand series which are exhibiting strong absorption at the longer 
wavelength with efficient NIR emission at 980 nm for ytterbium lanthanide complexes. 
30 
1 .7  Objectives 
To synthesize ytterbium (III) complexes using BODIPY dyes with a large n­
conjugation system. 
Modify the regular BODIPY dyes to enhance the absorption and emission 
wavelengths up to the deep red and NIR regions through Sonogashira coupling 
reaction at either 2 or 6 p positions of BODIPY dyes. 
Employ the other p position of BODIPY-bipyridine ligand by binding iodine 
group to enhance the ligand triplet state population. 
Attach 4-ethynylbenzoic acid and 1 -ethynyl-4-isothiocyanatobenzene anchors by 
replacing the iodine group at p position to make a large conjugated system. 
Synthesize a series of novel Yb(III) complexes that can be sensitized by the new 
BODIPY ligands. 
Characterize the intermediates and final products via 1H NMR spectroscopy. 
Record the UV -Vis, excitation and emission spectra of the ligands and their 
complexes .  
Measure the fluorescence quantum yield of ligands. 




2 .1 . 1  Materials 
All reagents and solvents were obtained from commercial sources (Aldrich, Sigma, Acros 
Organic, and Fisher Scientific) and were used without further purification unless 
otherwise stated. Dichloromethane (DCM), chloroform, hexane, methanol and 
triethylamine were purchased from Fisher Chemical Scientific. The 2,3 -dichloro-5,6-
dicyano- 1 ,4-benzoquinone (DDQ) was supplied by BIOSYNTH chemistry & biology. 
The N-iodosuccinamide (NIS), deuterated chloroform, tetrahydrofuran, copper (I) iodide, 
bis(triphenylphosphine)palladium(II)chloride (Pd(PPh3)2Ch), boron trifluoride diethyl 
etherate (BF30Eti), 2,4-dimethylpyrrole, dry CH2Ch, and K1C03 were purchased from 
ACROS Organics. The ytterbium (III) hexafluoroacetylacetonatedihydrate (99.9%) was 
purchased from STREM Chemicals .  The 5-bromo-5'-methyl-2,2'-N-bipyridine was 
synthesized according to a published procedure . 52 The 5-(trimethylsilyl)ethynyl-5 ' -
methyl-2,2'-N-bipyridine was synthesized in collaboration with Dr.  Radu Semeniuc, 
Eastern Illinois University. All, air and moisture sensitive reactions were conducted using 
either Schlenk techniques or in a MBRAun dry box under an inert atmosphere of dry 
nitrogen or argon. The nitrogen and argon gas were supplied by Geno Welding (Mattoon, 
IL) . The 70-230 mesh silica gel was purchased from SILICYCLE Inc. The column 
chromatography was performed over 70-230 mesh silica gel. 
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2.1 .2 Instrumentation 
NMR spectra were obtained on a Bruker Avance II-NMR 400 MHz spectrometer. 
Chemical shifts (8) were reported as ppm using the internal standard CDCb 99.8% D, 
containing 0.03% (v/v) TMS .  UV-VIS absorptions were measured on a Cary 1 00 Series 
UV-VIS Dual Beam Spectrometer over a range of 200 - 800 nm . The fluorescence 
























Figure 2.1 Synthetic overview of PHI ,  PH2, PH3 , and PH4 ligand and four ytterbium metal 
complexes. 
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2 .1 . 1  Synthesis of C19ff19BF2N2 (PS 001) 
+ 
Figure 2.2 Synthesis of PSOO 1 
_-:;::; N........_ / N  
B 
/ \  F F 
PSOOl 
To a distilled dichloromethane (200.0 mL) solution of benzaldehyde (0.45 mL, 4.4 1 
mmol) was added 2,4-dimethyl pyrrole (0.97 mL, 9.42 mmol) under nitrogen. A drop of 
BF3 .EhO was added after 1 5  min and the reaction mixture was stirred magnetically at 
room temperature for overnight. To this solution 2,3 -Dichloro-5,6-dicyano- 1 ,4-
benzoquinone (0 . 9 12  g, 4 .0 1 mmol) was added over ten minutes while keeping the flask 
in an ice bath. The solution became dark purple immediately. After stirring for 2h, 
triethylamine ( 4 .0  mL, 28 .00 mmol) was added slowly and the solution was stirred for 
30min. Then BF3 .EhO (4 .0 mL, 32 .4 1 mmol) was added dropwise into the mixture and 
the solution became fluorescent immediately under a UV lamp, indicating the formation 
of the final product. The reaction mixture was magnetically stirred overnight, 
concentrated under reduced pressure and purified using column chromatography (silica 
gel, CH2Ch: Hexane = 1 : 1 , v/v) to give PSOOl as an orange powder. Yield: 0 .42 1 g, 
29.46%. 1H NMR (400 MHz, CDCb) & 7.49 (m, J = 1 .4 Hz, 2H, He, Hd), 7 .29 (m, 2H, 
Hb), 5 .98 (s, 2H, Ha) ,  2 .56 (s, 6H, He) ,  1 . 37  (s, 6H, Hr) .  
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2.2.2 Synthesis of C19H1sBF2IN2 (PS002) 
PS 001 PS 002 
Figure 2.3 Synthesis of PS002 
N-Iodosuccinimide (0 . 1 40 g, 0 .62 mmol) in CH2Ch (30 .0 mL) was added dropwise to a 
solution of PSOO l (0.200 g, 0 .62 mmol) in CH2Ch ( 1 00 .0 mL) within l h  at 1 0- 1 5°C.  
After the addition, the reaction mixture was magnetically stirred Sh at room temperature . 
The reaction mixture was concentrated under reduced pressure and the crude product was 
purified by column chromatography (silica gel, CH2Ch: Hexane = 1 : 1 ,  v/v) to give 
PS002 as a dark orange color powder. Yield : 0 . 1 85 g, 66 .3%.  1H NMR (400 MHz, 
CDCb) () 7 .53  (m, 3H, He, H<l) ,  7 . 30  (m, 2H, Hb),  6 .07 (s, l H, Ha),  2 .66 (s, 3H, Hg), 2 .59  
(s, 3H, He), 1 .40 ( s ,  6H, Hf, Hh) .  
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2.2.3 Synthesis of CnH10N2 (PS003) 
First step 
-0-0-·· + 1 1  
H 
Figure 2.4 (a) Synthesis of PS003-step one 
PdCh(PPh3)2 (0.422 g, 0 .60 mmol), Cul (0. 1 90 g, 0 .99 mmol), and 5-bromo-5 '-methyl-
2.2 '-bipyridine ( 1 .000 g, 4 .00 mmol) were dissolved in a dry THF (30 .0 mL) and 
triethylamine ( 1 0 .0  mL, 7 1 . 60 mmol) mixture under a nitrogen atmosphere . 
Ethynyltrimethylsylane ( 1 .4 mL, 1 0 .02 mmol) was added to the solution and the resulting 
mixture was stirred overnight at room temperature . The reaction mixture was filtered and 
the volatiles were removed under reduced pressure, to afford a black powder. The 
product was purified by flash chromatography (silica gel, CH2Ch). Then Soxhlet 
extracted with hexane to give product as a pale brown color powder. Yield: 0 .885  g, 
82 .8%. 1H NMR (400 MHz, CDCb) � 8 . 72 (s, l H), 8 .48 (s, l H), 8 . 32  (d, 2H), 7 .85  (d, 






Figure 2.4 (b) Synthesis of PS003 -step two 
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5-(Trimethylsilyl)ethynyl-2,2 ' -bi pyridine (0.264 g, 0 .99 mmol) and K1C03 (0 .250 g, 1 . 80 
mmol) were dissolved in methanol (50 .0 mL) and stirred for one hour at room 
temperature . The solution was decanted and the solvent was removed in vacuo to afford 
pale yellow color powder as a PS003 . Yield: 0 . 1 82 g, 95 %. 1H NMR (400 MHz, CDCb) 
o 8 .75 (s, lH, Hd ) , 8 . 5 1 (s, lH, He) , 8 . 36  (d, J = 8 . 1  Hz, lH, H�, 8 . 30  (d, J = 8 . 1  Hz, l H, 
Ha) , 7 .89 (d, J = 8 . 3  Hz, lH, He) , 7 .87 (d, 8 . 3  Hz, l H, Hb) ,  3 .28 (s, lH, Hg), 2 .40 (s, 3H, 
Hh). 
2.2.4 Synthesis of C32H21BF2N4 (ligand PHl) 
I + 
P S002 1 1  PS003 
Figure 2.5 Synthesis of ligand PHl 
PH I 
Compound PS002 (0. 1 07 g, 0 .240 mmol), 5-ethynyl-5 '-methyl-2,2'-N-bipyridine (0 .046 
g, 0.237 mmol), Cul (0 .004 g, 0 .024 mmol) and PdCh(PPh3)2 (0 .0 1 6  g, 0 .024 mmol) 
were dissolved in THF (30.0 mL) and Et3N ( 1 0 .0 mL) in a pressure tube under argon. 
The reaction mixture was stirred at 50°C for two days. Then the reaction mixture was 
concentrated under reduced pressure and the crude product was purified using column 
chromatography (silica gel, CH2Ch:MeOH = 1 0 : 1 ,v/v) to give PHl as a purple color 
solid. Yield: 0 . 1 27 g, 5 1 .6%. 1H NMR (400 MHz, CDCb) o 8 .70 (s, lH, Hj), 8 . 5 1 (s, lH, 
He), 8 . 32  (d, l H, Hg), 8 . 3 1 (d, l H,Hh ), 7 . 84 (d, l H, Hi), 7 .63 (d, J = 8 .3  Hz, lH, Hr), 
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7 .5 1 (m, 3H, He, Hd) ,  7 .30 (m, 2H, Hb), 6 .05 (s, l H, Ha), 2 .72 (s, 3H, H1), 2 .59 (s, 3H, 
H0), 2.40 (s, 3H, Hm), 1 . 52 (s, 3H, Hn) ,  1 .4 1  (s, 3H, Hk) .  
2.2.5 Synthesis of C32H26BF2IN4 (ligand PH2) 
PH I PH2 
Figure 2.6 Synthesis of l igand PH2 
Compound PHl (0 . 1 85 g, 0 .3 5mmol) was dissolved in CH2Ch ( 1 00.0 mL) and then N­
iodosuccinimide (0.078 g, 0 . 35  mmol) in CH2Ch (40 .0 mL) was added drop wise to the 
reaction flask at 1 0- 1 5°C within 30  min. The reaction mixture was magnetically stirred 
over night at room temperature. Then the reaction mixture was concentrated under 
reduced pressure and the crude product was purified using column chromatography 
(silica gel, CHCh) to give PH2 as a dark purple color powder. Yield: 0 . 1 86 g, 82 .85%. 1H 
NMR (400 MHz, CDCh) 8 (ppm) 8 .7 l (s, lH, Hj), 8 . 5 1 (s, lH, He), 8 . 37(d, l H, Hg), 
8 . 3 1 (d, l H, Hh) ,  7 . 84(d, lH, Hi) ,  7 .63 (d, l H, Hr), 7 .54(m, 3H, He, Hd), 7 . 30(m, 2H, Hb), 
2 .73 (s, 3H, H1), 2 .67(s, 3H, H0) , 2 .40(s, 3H, Hm), 1 . 52(s, 3H, Hn), 1 .42(s, 3H, Hk) .  
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2.2.6 Synthesis of C41H31BF2N4Q2 (ligand PH3) 
+ HOOC� -- Hooe 
PH2 PH3 
Figure 2. 7 Synthesis of ligand PH3 
4-Ethynylbenzoic acid (0.0 1 5  g, 0 . 1 mmol), compound PH2 (0.065g, 0 . 1 mmol), Cul 
(0.002 g, 0 .0 1  mmol) , Pd2(PPh3)2Ch (0.007 g, 0 . 0 1  mmol) were dissolved in THF (30 .0 
mL) and Et3N ( 1 0 .0 mL) in a pressure tube under argon. Reaction was magnetically 
stirred for 24 h at 50°C. Then the reaction mixture was concentrated under reduced 
pressure and the crude product was purified using column chromatography (silica gel, 
CHCb: MeOH = 1 0 :2) to give PH3 as a red color solid. Yield: 0 .025 g, 37 . 87%. 1H NMR 
(400 MHz, CDCb) o (ppm) 8 . 7 1  (s, lH, Hj), 8 . 5 l (s, lH, He), 8 . 36  (dd, 2H, Hq), 7 .84 (d, 
l H, Hg), 7 .72 (d, l H, Hh), 7 .65 (d, l H, Hi), 7 .54 (m, SH, He, Hd, HP), 7 .48 (d, l H, Hr), 
7 .29 (m, 2H, Hb) ,  2 .73 (s, 3H, H1) ,  2 .67 (s, 3H, H0), 2 .40 (s, 3H, Hm), 1 . 52 (s, 3H, Hn), 
1 .42 (s, 3H, Hk) .  
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2.2. 7 Synthesis of C9HsNS (PS004) 
s 
>----==-H + Cl)lCI 
Figure 2.8 Synthesis of PS004 
SCN 
4-Ethynylbenzenamine ( 1 .000 g, 8 . 53  mmol) and trimethylamine (5 .0 mL, 3 5 . 82 mmol) 
in CHCb ( 1 5 . 0  mL) were placed in a flask under an atmosphere of Nz. A solution of 
thiophosgene (3 .0 mL, 1 9 . 30  mmol) in 20.0 mL CHCb was added dropwise at room 
temperature within one hour. The mixture was heated under reflux for 2h, and then 
cooled to room temperature. The mixture was quenched by addition of 20.0 mL cold 
water and extracted with 300.0 mL (3 x l OO .O mL) CHCb. The organic layer was washed 
with HzO (3 x 50 .0 mL), dried over anhydrous Na2S04 and concentrated to give a yellow 
residue. The crude product was purified using column chromatography (silica gel, 
Hexane : DCM = 3 : 1 )  to give PS004 as a pale yellow color solid. Yield : 0 .87 g, 64%. 1H 
NMR (400 MHz, CDCh) 8 (ppm), 7.47 (d, 2H, He), 7 . 1 8  (d. 2H, Hb), 3 . 1 6  (s, lH, Ha) . 
2.2.8 Synthesis of C41ff30BF2NsS (ligand PH4) 
+ SCN-0-== --- SCN 
PH2 PH4 
Figure 2.9 Synthesis of ligand PH4 
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1 -Ethynyl-4-isothiocyanatobenzene (0 . 0 1 6  g, 0 . 1 00 mmol), ligand PH2 (0.064 g, 0 . 1 00 
mmol), Cul (0.002 g, 0 .0 1 0  mmol), Pd2(PPh3)2Ch (0.007 g, 0 .005 mmol) were dissolved 
in THF (30 mL) and Et3N ( 1 0  mL)in a pressure tube under argon. The reaction mixture 
was magnetically stirred for 24 h at 50°C. Then the reaction mixture was concentrated 
under reduced pressure and the crude product was purified using column chromatography 
(silica gel, CHCb : MeOH = 1 0 :2) to give PH4 as a purple color solid. Yield : 27 mg, 
40%. 1H NMR (400 MHz, CDCb) () 8 . 70 (s, l H, Hm), 8 . 50  (s, l H, Hj), 8 . 3 5  (dd, 2H, Hb), 
7 . 84 (d, lH, Hk) ,  7 .70 (d, l H, H0), 7 .63 (d, l H, Hn ), 7 .54 (m, 5H, Hh, Hi, Ha),7.40 (d, l H, 
H1), 7 . 30  (m, 2H, Hg), 2 .73 (s, 3H, H�, 2 .67 (s, 3H, He), 2.40 (s, 3H, He), 1 . 52 (s, 3H, Hd), 
1 .42 (s, 3H, HP) . 
2.2.9 Synthesis of C24H27BF2N2Si (PS005) 
.....-::::::: N......._ / N  
B 
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Figure 2.10 Synthesis of PS005 
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PS005 
Compound PS002 (0 .360g, 1 .44 mmol), Cul (0 .0 1 5  g, 0 .08 mmol) and PdCh(PPh3)2 
(0 .056 g, 0 .08mmol) were dissolved in THF (30 mL) and Et3N ( 1 0  mL). 
Ethynyltrimethylsilane (0.22 mL, 1 .60 mmol) was added under argon. The reaction 
mixture was stirred at 50°C for 24 h. Then the reaction mixture was concentrated under 
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reduced pressure and the crude product was purified using column chromatography 
(silica gel, CH2Ch:hexane = 1 : 1 ,v/v) to give PS005 as a light orange color solid. Yield : 
0 . 38  g, 65 .3%.  1H NMR (400 MHz, CDCb) o 7 .50 (m, 3H, Hi, Hh), 7 .27 (m, 2H, Hj), 6 .02 
(s, l H, Ha), 2 .63 (s, 3H, He) , 2 . 57  (s, 3H, Hb), 1 .43 (s, 3H, He), 1 . 39  (s, 3H, Hd), 0.20 (s, 
9H, Hk) .  
2.2. 10 Synthesis of C21H19BF2N2 (PS006) 
I 
·>---==--Si-
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Figure 2.11 Synthesis of PS006 
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Compound PS005 (0.229 g, 0 .56 mmol) and K1C03 (0. 1 33 g, 0 .95 mmol) were combined 
in methanol (50 .0 mL) and stirred for one hour at room temperature. The reaction was 
quenched by adding H10 (40 .0 mL) and product was extracted with CH2Ch (40 .0 x 2 
mL) . The solvent was removed in vacuo and the crude product was purified using 
column chromatography (silica gel, CH2Ch:hexane = 1 :  1 )  to give PS006 as an orange 
color solid. Yield: 0 . 1 24 g, 63 . 58%. 1H NMR (400 MHz, CDCb) o 7 .5 1 (m, 3H, Hi, Hh), 
7 .28 (m, 2H, Hj) ,  6 .04 (s, lH, Ha),3 .28 (s, l H, Hk), 2 .64 (s, 3H, He), 2 . 58  (s, 3H, Hb), 1 .44 
(s, 3H, He), 1 .3 9  (s, 3H, Hd) .  
43 
2.2. 1 1  Synthesis of ytterbium complexes 
R 
Figure 2.12 Synthesis of ytterbium metal complexes 
All four ytterbium complexes were synthesized using a similar method. A typical 
procedure is described here using the ligand PHl . The PHl ligand (0.052 g, 0 . 1 0  mmol) 
was dissolved in CH2Ch (50 .0 mL), then [Yb(hfhc)3 · (H20)2] (0.079 g, 0 . 1 0  mmol) in 
CH2Ch ( 1 5 .0 mL) was added to the ligand solution. The resulting mixture was 
magnetically stirred for 1 h at room temperature,and then concentrated under reduced 
pressure . The crude product was recrystallized using CH2Ch and hexane. Yields : PHI -
Yb, 0 . 1 20 g 94.5%; PH2-Yb, 0 . 1 32 g 94.3%; PH3-Yb, 0 . 1 3 5  g 95 .2%; PH4-Yb, 0 . 1 3 3  g 
93%. 
2.3 Measurements 
2.3 .1  UV-VIS Absorption Spectra in Solution 
Electronic absorption spectra in the UV-Vis region were recorded on a Cary 1 00 Series 
UV-VIS Dual Beam Spectrometer using 1 .0 cm glass cells at room temperature. The 
absorption spectra of ligands and complexes were obtained in CH2Ch. The stock solution 
concentration of the samples was 2 .0x l 0-4 M in CH2Ch, and 50 µL of each was added to 
2 .5  mL of CH2Chin a 1 .0 cm glass cuvette . The spectra were recorded from 200-800 nm . 
The final concentration of each dye was 3 . 9 x 1 0-5 M (Table 2 . 1 ) .  
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Table 2 .1  Concentration of dye solutions used for UV-Vis absorbance measurement. 
Compound Used mass Cone. of Vol. of Vol. of Cone. Of 
for stock stock stock used diluted diluted 
solution solution in cuvette solution solution 
(mg) (mol/L) (µL) (CH2Ch) (mol/L) 
used in 
cuvette (mL) 
PHI  2 . I 2  2 x I 04 50 2 . 5  3 .9 x 1 0-5 
PH2 2 .62 2 x I 04 50 2 . 5  3 . 9  x 1 0-5 
PH3 2 .64 2 x I 04 50 2 .5  3 .9 x 1 0-5 
PH4 2.69 2 x I 04 50 2 . 5  3 . 9  x 1 0-5 
PHI -Yb 2 .57  2 x I 04 50 2 .5  3 .9 x 1 0-5 
PH2-Yb 2 . 8 I 2 x I 04 50 2 . 5  3 . 9  x 1 0-5 
PH3-Yb 2 .83  2 x I 04 50 2 . 5  3 . 9  x 1 0-5 
PH4-Yb 2 .86 2 x I 04 50 2 . 5  3 . 9  x 1 0-5 
2.3 .1  Fluorescence measurements 
Visible emission and excitation spectra of ligands and complexes were acquired using 
steady-state excitation on a spectrofluorometer with a Xenon arc lamp as a light source. 
The same stock solutions (Table 2 . I ) were used for the fluorescence measurements and 
each of the solution was diluted in 2 . 5  mL of CH2Ch to obtain I .6  x I o-6 M final 
concentration. The samples were excited at 375nm on FS5 spectroflourometer to obtain 
emission spectra of the ligands and complexes in UV -Vis region. 
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2.3.1  Quantum measurements 
Visible em1ss1on spectra were acquired usmg steady-state excitation and absorbance 
spectra of the same samples were obtained using UV -Vis spectrophotometer. Quantum 
yield in the visible region was calculated using the following equation: 
0x = 0sT 
[ Gradx ] [�] 
GradsT nsT 
where 0x is the fluorescence quantum yield of compound, 0sT is the standard 
fluorescence quantum yield (0x= 0 .95 ,  A.ex = 480 nm), Gradx is the gradient from the plot 
of the intergraded fluorescence intensity vs absorbance of ligands and complexes with 
different concentrations, GradsT is the gradient from the intergraded fluorescence 
intensity vs absorbance of Rhodamine 6G standard in ethanol, 11X and 11ST are refractive 
index of the compound and standard dissolved solvents, respectively. (11DCM = 1 .424 1 ,  
11EtOH = 1 .3 6 1 4) 
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Ex: Quantum yield measurements for PHI  ligand 
Table 2.2 Concentration of PHI ligand used for quantum yield measurement. (Stock solution 
concentration 2x I 0-4 M in CH2Cb) 
Vol. of stock used in 
cuvette (µL) 
5 
1 0  
1 5  
25 
3 5  
Vol. o f  diluted solution 
(DCM) used in cuvette 
(mL) 
2 .5  
2 .5  
2 . 5  
2 . 5  
2 . 5  
Cone. Of diluted solution 
(mol/L) 
3 .99x 1 0-7 
7 .98x 1 0-7 
l . 1 9x 1 0-6 
l .99x 1 0-6 
2 .79x 1 0-6 
First step : UV-Vis absorption spectra of PHI ligand were obtained usmg different 
concentrations as shown in table 2.2 .  
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Figure 2.13 UV-Vis absorbance of PH I ligand in CH2Cb. 
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Second step : The fluorescence spectra of PHl ligand were obtained usmg same 
concentration (monitored at 480 nm). 
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Figure 2.14 UV-Vis fluorescence spectra of PH I l igand in CH2Ch.A.ex= 480 run. 
Third step : Quantum yield was calculated using the slope from the plot of the intergraded 
fluorescence intensity vs absorbance of PHl ligands at 480 nm in CH2Chand slope from 
the intergraded fluorescence intensity vs absorbance of rhodamine 6G standard at 480 nm 
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Figure 2.15 Plot of Fluorescence intensity vs absorbance of PH I ligand in CH2Ch at 480 nm. 
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Quantum yield measurements for PH2 ligand 
Table 2.3 Concentration of PH2 ligand used for quantum yield measurement. (Stock solution 
concentration 2x 10-4 M in CH2Cb) 
Vol. of stock used in Vol. of diluted solution 
(DCM) used in cuvette 
(mL) 
Cone. Of diluted solution 
cuvette (µL) 





2 .5  
2 .5  
2 . 5  
2 . 5  
2 . 5  
(mol/L) 
7.97x 1 0·7 
1 . 59x 1 0·6 
2 .39x 1 0"6 
3 . 1 8x t o·6 
3 .98x t o·6 
First step : UV-Vis absorption spectra of PH2 ligand were obtained usmg different 
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Figure 2.16 UV-Vis absorbance of PH2 ligand in CH2Ch. 
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Second step : The fluorescence spectra of PH2 ligand were obtained usmg same 
concentration (monitored at 480 nm). 
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Figure 2.17 UV-Vis fluorescence spectra of PH2 ligand in CH2Ch.A.ex= 480 nm. 
Third step : Quantum yield was calculated using the slope from the plot of the intergraded 
fluorescence intensity vs absorbance of PH2 ligands at 480 nmin CH2Chand slope from 
the intergraded fluorescence intensity vs absorbance of rhodamine 6G standard at 480 nm 
in ethanol .  
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Figure 2.18 Plot of Fluorescence intensity vs absorbance of PH2 ligand in CH2Ch at 480 nm. 
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2.3.2 Lifetime measurement in the Vis region 
A pulse diode laser (EPL-375 , Edinburgh Instruments, Inc) with excitation wavelength at 
375nm was used as the light source and life times were obtained by exponential fitting of 
decay curves. Decay curves of the sample in the visible region were acquired using a 
time-correlated single photon counting (TCSPC) technique . The life times were 
calculated by exponential tail fitting of the data for visible emission. The concentration of 
the ligands and complexes were 1 .6 x 1 o-6 M. 
2.3.3 Lifetime measurement in the NIR region 
The ytterbium complexes were sent out to Dr. May Stanley (South Dakota University) to 
obtain lifetime measurements in NIR region. NIR decay curves were acquired using an 
optical parametric oscillator (OPTEK Opelette) as an excitation source. NIR emission 
was detected using a 0 .3  m flat field monochromator (Jobin Yvon TRIAX 320) equipped 
with a NIR-sensitive photomultiplier tube (Hamamatsu R2658P). The intrinsic quantum 
yield (0ig) of ytterbium complexes were calculated using lifetimes in NIR region using 
following equation. 
Yb @yb = tabs _ tr ad 
tabs 
2 3 0 0  µs 
'tobs = Observed lifetime of ytterbium complex 
'trad = Radiative lifetime of Yb3+ (2300 µs) 
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2.3.4 Spectroscopic titration 
The spectroscopic titration curves in the visible and NIR region were obtained by titrating 
PHI , PH2, PH3 and PH4 ligands solutions ( l x I Q-6 M) in CH2Chwith [Yb(hfac)3 · (H20)2] 
(4x 1 0-5 M) solution separately. The visible region emission spectra were obtained using 
steady state excitation at 375 nm . NIR emission spectra were acquired at 980 nm 
emission wavelength and excited at their own maximum wavelengths (PHI -Yb; 542 nm, 
PH2-Yb; 562 nm, PH3-Yb; 570 nm, PH4-Yb; 55  I nm) .  
2.3.5 Crystallography 
Single crystals of PSOO I were obtained by slow evaporation of CH2Ch-hexane solution 
and PH2-Ybwasobtained by vapor diffusion of same solution at room temperature. The 
crystals were wrapped with paraton-N oil and mounted on glass fibers. The diffraction 
measurements were made on Bruker APEXII CCD detector at I 00 K. The structure was 
refined on F2 using the SHELXS software package. Relevant crystal data and structure 
refinement details for PSOO I and PH2-Yb are listed in (Table 2 .  I ) . 
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Table 2.4 Crystal data and structure refinement details for PSOO I and PH2-Yb 
PSOOl PH2-Yb 
Empirical formula C19H19BF2N2 C4sH3 1BChF20IN406 Yb 
Formula weight 324. 1 7  1 52 1 .42 
T/K 1 00 1 00 
Crystal system Orthorhombic Monoclinic 
Space group Pb ca P2 i/C 
Cell dimensions 
a!A 1 3 . 1 43 1 (6) 1 2 .66 1 9  (5) 
b/A 12 . 7 1 29 (5) 1 8 .7236 (8) 
c/A 20.5093 (8) 22.66 1 ( 1 )  
a 90° 90° 
p 90° 9 1 .456° (2) 
'Y 90° 90° 
Volume/A3 3426 .8  (2) 5370 .7 (4) 
z 8 4 
µ(Cu-Ka)/mm·1 0 .73 9 .76 
No.of reflection/restraints 305 1 /0/222 9827 /78/755 
No.of parameters 
Riot 0 . 1 08 0 . 1 50 
Final R indices R1= 0 .066 R1= 0 .052 
wR2= 0 . 1 86 wR2= 0 . 1 32 
Goodness-of-fit on F2 0.99 1 .02 
Refl.collected/independent 42493 ,305 1 8 1 326,9827 
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CHAPTER 3 
RESULTS AND DISCUSSION 
3.1  Synthesizing and purification 
The synthetic strategy for preparing metal complexes of BODIPY-bipyridine ligands 
followed the steps shown in Figure 2 . 1 .  2,4-Dimethylpyrrole and benzaldehyde were 
reacted in distilled dichloromethane at room temperature, followed by addition of 2,3-
dichloro-5 ,6-dicyano- 1 ,4-benzoquinone (DDQ) for oxidation and BF3 · 0Eti for 
coordination in the presence of EfaN. The reaction mixture was filtered through silica gel 
to remove the impurities from the reaction mixture. Then, it was easy to purify the 
reaction mixture using column chromatography. The prepared 5-ethynyl-5 '-methyl-2,2'-
N-bipyridine was used as a binding group to synthesize lanthanide metal complexes 
because the BODIPY core does not have the capability to form metal complexes. To 
synthesize the BODIPY-bipyridine ligand, we first introduced an iodine atom to the 
BODIPY core at either C2 or C6 position of the BODIPY core using N-iodosuccinimide 
(NIS) in CH2Chat room temperature. This reaction condition afforded two products : the 
mono and di-iodinated BODIPY. The similar polarities of these compounds made their 
purification difficult. CH2Ch:hexane ( 1 : 1 )  was found to be the best solvent system. 
However, it was difficult to separate the two bands as pure products. BODIPY-bipyridine 
(PHI ligand) was synthesized by Sonogashira cross-coupling reaction using iodinated-
BODIPY and 5-ethynyl-5 '-methyl-2,2'-N-bipyridine under argon condition. A purple 
color solid was obtained as the final product after purification of the reaction mixture via 
column chromatography. To make the extended conjugated system, BODIPY-bipyridine 
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(PHI )  was further iodinated (C2 or C6 positions) with NIS in CH2Ch solution at room 
temperature. The synthesized iodinated BODIPY-bipyridine (PH2) was modified using 4-
ethynylbenzoic acid (PH3) and I -ethynyl-4-isothiocyanatobenzene (PH4) under the 
Sonogashira cross-coupling reaction conditions. The final products were purified using 
column chromatography after several solvent systems were tested to obtain a clear band 
separation. 
Four ytterbium (III) complexes were synthesized using the ligands PHI , PH2, PH3 and 
PH4 with ytterbium hexafluoroacetyl-acetonatedihydrate [Yb(hfac)3 · (H20)2] in CH2Ch at 
room temperature. This reaction was straightforward, and the mixture was purified by 
using recrystallization. First, methanol was tried as a recrystallization solvent, but the 
disappearance of emission at NIR region was observed. After that, hexane was used as a 
solvent and a clear emission spectrum in the NIR region was observed. According to the 
observations, methanol could trigger the decomposition of these ytterbium complexes .  
SS 
3.2 Characterization 
All compounds were characterized by 1 H NMR spectroscopy; in addition, the structure of 
the PH2 ytterbium complex was confirmed by X-ray diffraction studies. 
3.2.1  NMR spectroscopy 






--:::::. N ......._ / N 
B 
/ \  
F F 
1H NMR (400 MHz, CDCb) & 7 .49 (m, J = 1 .4 Hz, 2H, He, Hct), 7.29 (m, 2H,Hb), 5 .98 (s, 
2H, Ha), 2 .56 (s, 6H, He), 1 . 3 7  (s, 6H, H� 
The 1H NMR spectrum for PSOO l is illustrated in the appendix (A. l ). Five major peaks 
were observed in the spectrum. The most deshielded three aromatic protons, labeled as c 
and d, produced a multiplet at 7 .49 ppm. The two aromatic protons, labeled as b, 
appeared as a doublet at 7.29 ppm. The two protons on C2 and C6 positions of pyrrole, 
labeled as a, produced a singlet at 5 .98 ppm. The methyl groups bound to the pyrrole 
adjacent to the nitrogen atoms, labeled as e, appeared as a singlet at 2 .56 ppm. The other 
two methyl groups on the BODIPY core, labeled as/, produced a singlet at 1 . 37  ppm. 
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1H NMR (400 MHz, CDCb) 8 7 .53  (m, 3H, He, Hct), 7 .30 (m, 2H, Hb), 6 .07 (s, lH, Ha), 
2 .66 (s, 3H, Hg), 2 .59 (s, 3H, He) , 1 .40 (s, 6H, Hr, Hh) .  
The 1H NMR spectrum for PS002 is illustrated in the appendix (A.2). Six major peaks 
were observed in the spectrum. The most deshielded three aromatic protons, labeled as c 
and d, produced a multiplet at 7 .53 ppm. The two aromatic protons, labeled as b, 
appeared as a doublet at 7.30 ppm. The one proton on p positions of pyrrole, labeled as a, 
produced a singlet at 6 .07 ppm. The methyl group bound to the pyrrole adjacent to the 
nitrogen atom and iodine atom, labeled as g, appeared as a singlet at 2 .66 ppm. The 
methyl group bound to the pyrrole adjacent to the nitrogen, labeled as e, produced a 
singlet at 2 .59 ppm. The other two methyl groups on the BODIPY core, labeled as f and 
h, produced a singlet at 1 .40 ppm. 
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3.2.1.c. 1 H NMR of Compound C13H10N2 (PS003) 
b a f e 
c 
1H NMR (400 MHz, CDCb) () 8 .75 (s, lH, Hd ), 8 . 5 1 (s, lH, He), 8 . 36  (d, J = 8 . 1 Hz, lH, 
Hr), 8 . 30  (d, J = 8 . 1  Hz, lH, Ha), 7 .89 (d, J = 8 .3  Hz, lH, He), 7 .87 (d, 8 . 3  Hz, lH, Hb), 
3 .28  (s, l H, Hg), 2 .40 (s, 3H, Hh) .  
The 1H NMR spectrum for PS003 i s  illustrated in the appendix (A.3) .  Eight major peaks 
were observed in the spectrum. The protons on pyridine ring adjacent to the nitrogen 
atoms, labeled as d and c, produced two singlets at 8 .75 ppm and 8 . 5 1 ppm respectively. 
The two protons, labeled asf and a, appeared as two doublets at 8 . 36  ppm and 8 . 30  ppm. 
The two protons, labeled as e and b, produced two doublets at 7 .89 ppm and 7.65 ppm, 
respectively. The methyl group bound to the pyridine ring, labeled as h, appeared as a 
singlet at 2.40 ppm. The proton on alkyne group, labeled as g, appeared as a singlet at 
3 .28  ppm. 
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3.2. 1.d. 1H NMR o/ CompoundC12H21BF2N4 ( PHI) 
d 
n 
f g h i 
H CH3 
a .....-:::::: N ........._ / N  k 
B e j / \  
F F l 0 
1H NMR (400 MHz, CDCb) 8 8 .70 (s, lH, Hj), 8 . 5 1 (s, l H, He), 8 . 32  (d, l H, Hg), 8 . 3 1 
(d, l H, Hh ), 7 . 84 (d, lH, Hi) ,  7 .63 (d, J = 8 . 3  Hz, lH, Hf), 7 . 5 1 (m, 3H, He, Hct), 7 .30 (m, 
2H, Hb), 6 .05 (s, lH, Ha) ,  2 .72 (s, 3H, H1), 2 .59 (s, 3H, H0), 2.40 (s, 3H, Hm), 1 . 52 (s, 3H, 
Hn), 1 .4 1  (s, 3H, Hk) . 
The 1H NMR spectrum for PHI is illustrated in the appendix (A.4). Fourteen major peaks 
were observed in the spectrum. The protons on pyridine ring adjacent to the nitrogen 
atoms, labeled as j and e, produced two singlets at 8 .70 ppm and 8 . 5 1 ppm respectively. 
The proton, labeled as g appeared as a doublet at 8 .3 2  ppm. The proton, labeled as h, 
produced a doublet at 8 . 3 1 ppm. The two protons, labeled as i and f, produced doublets at 
7 . 84 ppm and 7 .63 ppm, respectively. The two protons c and d which are bound to the 
aromatic ring of the BODIPY core produced a multiplet at 7 .5 1 ppm. The two aromatic 
protons b, which is close to the BODIPY core, appeared as a multiplet at 7 .30 ppm. The 
proton a on B position of pyrrole produced a singlet at 6 .05 ppm. The methyl groups 
bound to the pyrrole ring, labeled as /, o, m, and n, appeared as singlet peaks at 2 .72, 
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2 .59, 2 .40, and 1 . 52 ppm, respectively. The methyl group on pyridine group protons, 
labeled as k, produced a singlet at 1 .4 1  ppm. 
3.2.1 .e. 1 H NMR of Compound C31H26BF2/N4 (PH2) 
d 
c � 
b l  � n m 
f g h i 
CH3 
\ ;} � � N , / N  k 
B e N N j / \  
0 F F I 
1H NMR (400 MHz, CDCh) o (ppm) 8 .7 1 (s, l H, Hi), 8 . 5 l (s, lH, He), 8 . 37(d, lH, Hg), 
8 . 3 l (d, lH, Hh), 7 . 84(d, lH, Hi), 7 .63 (d, lH, H�, 7 .54(m, 3H, He, Hd), 7 . 30(m, 2H, Hb), 
2 .73 (s, 3H, H1) ,  2 .67(s, 3H, H0) , 2 .40(s, 3H, Hm), l . 52(s, 3H, Hn), l .42(s, 3H, Hk) .  
The 1H NMR spectrum for PH2 is illustrated in the appendix (A. 5) . Thirteen major peaks 
were observed in the spectrum. The protons on pyridine ring adjacent to the nitrogen 
atoms, labeled asj and e, produced two singlets at 8 . 7 1  ppm and 8 . 5 1 ppm, respectively. 
The two protons, labeled as g and h, appeared as two doublets at 8 . 37  ppm and 8 . 3 1 ppm. 
The two protons, labeled as i and f, produced doublets at 7 .84 ppm and 7.63 ppm, 
respectively. The two protons c and d which are bound to the aromatic ring produced a 
multiplet at 7 .54 ppm. The two protons labeled as b on the aromatic ring appeared as a 
multiplet at 7 . 30  ppm. The peak at 6 .05ppm related to the p position of PHI disappeared 
in the PH2 NMR spectrum by the iodine atom. The methyl groups bound to the pyrrole 
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ring, labeled as /, o, m, and n, appeared as singlet peaks at 2 .73 ,  2 .67, 2.40, and 1 . 52 ppm, 
respectively. The methyl group on pyridine group protons, labeled as /, produced a singlet 
at 1 .42 ppm. 
3.2.1.f. 1 H NMR of Compound C41H11BF2N402 (PH3) 
d 
n m 
f g h 
HO 
CH3 
,..-,:::::: N -......, ,....... N k 
q p B e j / \  
0 F F 
1H NMR (400 MHz, CDCb) 8 (ppm) 8 . 7 1  (s, l H, Hj), 8 . 5 1 (s, l H, He), 8 . 36  (dd, 2H, Hq), 
7 . 84 (d, l H, Hg) , 7 .72 (d, l H, Hh) ,  7 .65 (d, l H, Hi), 7 .54 (m, 5H, He, Hd, HP), 7 .48 (d, l H, 
Hr), 7 .29 (m, 2H, Hb) , 2 . 73 (s, 3H, H1), 2 .67 (s, 3H, H0), 2 .40 (s, 3H, Hm), 1 . 52 (s, 3H, 
Hn), 1 .42 (s ,  3H, Hk) . 
The 1H NMR spectrum for PH3 is illustrated in the appendix (A.6) . Fourteen major peaks 
were observed in the spectrum. The protons on the pyridine ring adjacent to the nitrogen 
atoms, labeled as j and e, produced a singlet at 8 . 7 1  ppm and 8 . 5 1 ppm respectively. The 
protons on the aromatic ring adjacent to the benzoic acid group, labeled as q, appeared as 
a double doublet at 8 . 36  ppm. The two protons labeled as g and h, produced doublets at 
7 . 84 ppm and 7 .72 ppm, respectively. The proton on bipyridine close to the methyl 
group, labeled as i produced a doublet at 7 .65 ppm. The aromatic protons c, d, and p have 
overlapped together and appeared as a multiplet at 7 .54 ppm. The proton on bipyridine 
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labeled as f appeared as a doublet at 7 .48 ppm. The two aromatic protons b produced a 
multiplet at 7 .29 ppm. The methyl groups bound to the pyrrole ring, labeled as /, c, e, and 
d, appeared as singlet peaks at 2 .73 ,  2 .67,  2 .40, and 1 . 52 ppm, respectively. The methyl 
group on pyridine group protons, labeled as k, produced a singlet at 1 .42 ppm. 
3.2.1.g. 1H NMR of Compound C9HsNS (PS004) 
a 
SCN j>---=:==--H 
.....__  _, 
c 
1H NMR (400 MHz, CDCh) � (ppm), 7 .47 (d, 2H, He), 7 . 1 8  (d. 2H, Hb), 3 . 1 6  (s, l H, Ha) . 
The 1H NMR spectrum for PS004 is illustrated in the appendix (A.7) . Three major peaks 
were observed in the spectrum. The protons on the aromatic ring adjacent to the alkyne 
group, labeled as c, produced a doublet at 7 .47 ppm, and the protons on the aromatic ring 
adjacent to the thiocyanide group, labeled as b, produced a doublet at 7 . 1 8  ppm. The 
proton on the alkyne group, labeled as a, appeared as a singlet at 3 . 1 6  ppm. 
3.2.1.h. 1H NMR of Compound C41H30BFiNsS (PH4) 
i 
d e 
b a k 0 n 
p 
SCN CH3 
......,;;;::: N ....._ ,.....-N 
B j / \  
c F F f 
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1H NMR (400 MHz, CDCb) 8 8 .70 (s, l H, Hm), 8 . 50  (s, l H, Hj), 8 . 35  (dd, 2H, Hb), 7 .84 
(d, l H, Hk), 7 .70 (d, l H, H0) , 7 .63 (d, l H, Hn ), 7 .54 (m, SH, Hh, Hi , Ha),7 .40 (d, l H, H1) , 
7 .30  (m, 2H, Hg), 2 .73 (s, 3H, Hr), 2 .67 (s, 3H, He), 2.40 (s, 3H, He), 1 . 52 (s, 3H, Hct), 
1 .42 (s, 3H, HP) . 
The 1H NMR spectrum for PH4 is illustrated in the appendix (A. 8) .  Fourteen major peaks 
were observed in the spectrum. The protons on the pyridine ring adjacent to the nitrogen 
atoms, labeled as j and m, produced a singlet at 8 .  70 ppm and 8 . 50  ppm respectively. The 
two protons, labeled as k and l, produced doublets at 8 .40 ppm and 8 .27 ppm, 
respectively. The two protons a and b on the aromatic ring, produced a multiplet at 7 .47 
ppm. The protons on the meso position aromatic ring, labeled as h and i, appeared as a 
multiplet at 7 .27 ppm. The methyl groups bound to the pyrrole ring, labeled as f, c, e, and 
d, appeared as singlet peaks at 2 .73 ,  2 .67, 2 .40, and 1 . 52 ppm, respectively. The methyl 
group on the pyridine group protons, labeled as p, produced a singlet at 1 .42 ppm. 







a � N ......_ / N  \ k  B 
/ \  
b F F c 
1H NMR (400 MHz, CDCb) 8 7 .50 (m, 3H, Hi , Hh), 7 .27 (m, 2H, Hj), 6 .02 (s, l H, Ha), 
2 .63 (s, 3H, He) ,  2.57 (s, 3H, Hb) ,  1 .43 (s, 3H, He), 1 . 39 (s, 3H, Hct), 0 .20 (s, 9H, Hk) .  
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The 1H NMR spectrum for PS005 is illustrated in the appendix (A.9) .  Seven major peaks 
were observed in the spectrum. The protons on aromatic ring I and h appeared as a 
multiplet at 7 .50 ppm, and the proton j, produced a doublet at 7 .27 ppm. The proton on 
the P position of BODIPY core, labeled as a, produced a singlet at 6 .02 ppm. The methyl 
group protons on the BODIPY core, labeled as c, b, e, and d, appeared as singlets at 2 .63 ,  
2 .57 ,  1 .43 , and 1 .3 9  ppm, respectively. The methyl protons on the silane group, labeled as 
k, produced a singlet at 0 .20 ppm. 
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1H NMR (400 MHz, CDCh) � 7 .5 1 (m, 3H, Hi, Hh), 7 .28 (m, 2H, Hj), 6 .04 (s, l H, H3), 
3 .28 (s, l H, Hk) ,  2 .64 (s, 3H, He) ,  2 . 58  (s, 3H, Hb), 1 .44 (s, 3H, He), 1 . 3 9  (s, 3H, Hct) .  
The 1H NMR spectrum for PS005 is illustrated in  the appendix (A.9) .  Eight major peaks 
were observed in the spectrum. The protons on the aromatic ring i and h appeared as a 
multiplet at 7 . 5 1  ppm, and the protons labeled as j produced a doublet at 7 .28ppm. The 
proton on the p position of BODIPY core, labeled as a, produced a singlet at 6 .04 ppm. 
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The product formation was confirmed by the proton k on alkyne group, which appeared 
as a singlet at 3 .28 ppm. The methyl group protons on the BODIPY core, labeled as c, b, 
e ,  and d, appeared as singlets at 2 .64, 2 . 58 ,  1 .44, and 1 .39  ppm, respectively. 
3.2.2 X-Ray Crystallography 
The structures of the PSOO 1 precursor and PH2-Yb complex were ascertained by single 
crystal X-ray diffraction analysis. For PSOO l ,  single crystals were obtained by slow 
evaporation of a dichloromethane and hexane, and for the PH2-Yb complex, single 
crystals were obtained by vapor diffusion method using the same solvent system. 
Perspective views of PSOO l and PH2-Yb are shown in Fig 3 . 1  while selected bond angles 
and bond lengths are summarized in Table 3 . 1 . According to the crystal data for PSOO l 
the crystal system is orthorhombic, and for the complex PH2-Yb the crystal system is 
monoclinic. The space groups are Pbca and P2i/c for PSOO l and PH2-Yb complex, 
respectively. The single crystal structure of PSOO l revealed that the phenyl group is 
almost perpendicular to the BODIPY core, as shown by the torsion angle between the 
two planes of the BODIPY core and benzene unit is 84. 1 5 ° (Figure 3 .2) .  The PH2-Yb 
crystal structure revealed that the Yb(III) ion is eight-coordinated by two N atoms from 
the bipyridine and six 0 atoms from the coordinated trifluoroacetic acid. The boron atom 
of the BODIPY core is in a tetrahedral geometry with bond angles averaging 1 09 .05° .  
According to the torsion angle between BODIPY core and bipyridine group, the two units 




Figure 3.1 ORTEP diagrams of a single-crystal structures of (a) PSOO I and (b) PH2-Yb with 
50% thermal ellipsoid probability. The H atoms were omitted for clarity. F atoms on each CF 3 
unit are disordered. 
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Figure 3.2 Torsion Angle between the two planes of the BODIPY core and phenyl ring 
Table 3.1  Selected bond lengths and bond angles of PSOO I and PH2-Yb(hfac)3 
Bond Bond length (A) 
N4-Ybl 2 .474(5) Bond Bond angle (0) 
N3-Ybl 2.468(5) 
N4-Ybl- N3 65 .3 (2) 
C4-11 2.089(7) 
N3- Bl- F2 1 1 0 .7(5) 
N2-Bl 1 . 566(9) 
N2- Bl- Fl 1 1 0 . 1 (5)  
Nl-Bl 1 .564(9) N2- Bl- Nl 1 06. 1 (5) 
Bl-Fl 1 . 390(8) 
Fl- Bl- F2 1 09 .3(5)  
Bl-F2 1 .3 87(8) 
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3.3 Photophysical Properties 
3.3 .1  UV-Vis Absorption 
The absorption spectra of ligands and complexes in CH2Ch are shown in Figure 3 . 3 ,  and 
the results are summarized in Table 3 .2 .  The data illustrates that the characteristic pattern 
of the four different ligands and their complexes .  The absorption coefficient and 
absorption wavelengths rely significantly on the substituent of BODIPY core . The 
ligands have strong absorptions from 537  to 573 nm; their complexes have similar 
absorption wavelengths between 535  -571  nm. As shown in Table 3 .2, the ligands PH1 -
PH4 exhibit longer wavelength absorptions at 537, 552,  573 and 553 nm, respectively. 
This data illustrates that the bathochromic shift of ligands varies with the higher 
conjugation of the system. The PSOO 1 produced a maximum absorption peak at 498 nm. 
Its absorption coefficient was 7 .34x 1 04 M- 1cm-1 • Upon iodination (PS002), the absorption 
shifted by 1 6  nm, with an absorption coefficient of 7. 3 1  x 1 04 M-1 cm-1 . Once the 5 -
ethynyl-5 '-methyl-2,2 '-N-bipiridinwas attached to the C2  o r  C6  position of  BODIPY 
core, the absorption was shifted by 3 7 nm to the longer wavelength and the absorption 
coefficient dropped down to 7 .43 x 1 03 M-1cm-1 • After synthesizing the n-conjugated 
molecule by employing the C2 or C6 position of BODIPY core with 4-ethynylbenzoic 
acid (PH3), the absorption peak red-shifted by 72 nm. Compared with the PH3 ligand, 1 -
ethynyl-4-isothiocyanatobenzene BODIPY ligand (PH4) exhibited a low red shift under 
the same conditions. The respective moderate and good electron withdrawing ability of -
COOH and -NCS groups may have influenced the absorption and emission properties of 
the new derivatized ligands . The extended conjugation reduces the energy gap between 
HOMO and LUMO energy level, thus broadens the absorption and emission wavelength 
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to longer wavelength reg10n. The bipyridine group significantly quenches the 
fluorescence of BODIPY core due to the internal charge transfer process between the 
donor bipyridine unit and the BODIPY core . The ligands and their complexes exhibited 
variable fluorescence intensities at a similar concentration. However, the PH3 ligand has 
lower absorption intensity than PH4, even though they both have quite similar n­
conjugation systems. The most probable reason is the lower solubility of the PH3 ligand 
in the CH2Ch solvent. The PH3-Yb complex has higher absorption intensity than the PH3 
ligand, and the other complexes have a more or less similar intensity to the ligands. Also, 
one shoulder peak was observed at 623 nm in PH3 ligand absorption spectrum and this 
peak was disappeared with MeOH. The PH3 ligands have some possibility to make acid­
acid hydrogen bonding dimer and acid-pyridine hydrogen bonding polymer 
intramolecular interactions (Figure 3 .4) .This hypothesis was confirmed by titrating the 
PH3 ligand with MeOH. Interestingly, two sharp absorption peaks were observed in UV 
spectrum at 573 nm and 625 nm (without MeOH), and the absorption peak at 625 nm 
disappeared as a result of MeOH addition (Figure 3 . 5) .  Also, the emission intensity at 
UV-Vis region was increased with the MeOH (Figure 3 .6). The MeOH molecules can 
interact with -COOH groups instead of the nitrogen lone pairs . As a consequence of 
these interactions, the PH3 ligand becomes free molecules in the solution and gave one 
absorption peak corresponding to the PH3 ligand. Also, the fluorescence emission peak 
intensity was increased with the MeOH. 
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Figure 3.3 .  (a) Experimental UV-Vis absorption spectra of PHI ,  PH2,  PH3 , and PH4 ligand in 
CH2Ch (3 .9x i o-5 M), (b) Experimental UV-Vis absorption spectra of PHI -Yb, PH2-Yb, PH3-Yb, 
and PH4-Yb ligand in CH2Ch (3 .9x 1 0-5 M) 
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Table 3.2 Absorptivity and maximum absorption wavelengths of PHI ,  PH2, PH3 and PH4 
ligands and their complexes in CH2Cb.  
Compound Absorbance E (M-1cm-1 ) Amax (nm) 
PSOO I 2 .89 I 7 .34x 1 04 498 
PS002 2 .207 7 .3 I x 1 04 5 I 6  
PHI 0 .290 7.43 x 1 03 535  
PH2 0 .3 I 4  8 .05 x 1 03 549 
PH3 O . I 85 4 .74x I 03 570 
PH4 0 .353  9 .04x 1 03 5 5 I  
PHI -Yb 0 . 339  8 .69x 1 03 533  
PH2-Yb 0. 3 7 I  9 .5 I x 1 03 545 
PH3-Yb 0 .325 8 . 33 x 1 03 569 
PH4-Yb 0 .4 I O  1 0 . 5 I x 1 03 550  
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Figure 3.5 UV-Vis spectral changes of the PH3 ligand in dry CH2Cbupon addition of different 
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Figure 3.6 Emission spectra of the PH3 ligand before adding MeOH and after adding MeOH. 
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3.3.2 Fluorescence Spectroscopy 
The emission and excitation spectra for PHI -PH4 ligands and their complexes in the 
visible region are shown in Figure 3 .7 and Figure 3 . 8 ,  respectively, and the spectral data 
is summarized in Table 3 .3 and Table 3 .4 .  The maximum absorption and excitation 
wavelengths of ligands and complexes were similar to each other. The emission 
wavelength of the PH I ligand was at 542 nm, and has the lowest emission wavelength 
compared with the other compounds. PH3 ligand and its complex have longer emission 
wavelength around 597 nm and 592 nm. Also, emission wavelength was increased from 
PH I  to PH4, whereas PH3 ligand and its complex exhibited the longest emission 
wavelength in the visible region. The emission intensity decreased from PHI  to PH2 
ligand by 3 5%. Heavy atoms like iodine facilitate the triplet state of ligand and, it 
quenches the initial fluorescence of the ligand in the visible region. Extension of the n­
conjugation system in BODIPY precursor from bipyridine, 4-ethynylbenzoic acid and I ­
ethynyl-4-isothiocyanatobenzene caused a significant redshift in their absorption and 
emission (Figure 3 .9) . The emission wavelengths of BODIPY bipyridine derivatives 
appear in the range of 500 - 600 nm, which was related to the BODIPY molecule 
emission wavelengths. It can be concluded that the energy transfer occurs from the 
BODIPY chromophore to the Yb(III) ion. According to the data, PH I  has lowest 
excitation wavelength at 533  nm, and PH3 ligand has highest excitation wavelength at 
57 I  nm . This observation illustrates the fact that the extended conjugated system 
compounds absorb at lower energy for excitation than the non-conjugated compounds. 
The PH2 and PH4 ligands exhibited mostly similar excitation wavelengths 552 nm and 
5 5 I  nm in the visible region. The normalized excitation spectrum of ytterbium complexes 
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at 980 nm illustrates the best excitation wavelengths for maximum emission at NIR 
region (Figure 3 . 1 0) .  
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Figure 3.7  (a) Emission and (b) excitation spectra of PHl ,  PH2, PH3 , and PH4 ligands in  CH2Ch 
( 1 .6x 1 0-6 M). The excitation wavelength was 3 75 nm. The emission wavelengths for PHI :  570 
nm, PH2 :552  nm, PH3 : 571 nm and PH4: 55 1 nm 
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Figure 3.8 Normalized emission spectra of BODIPY precursor, PHI ,  PH2, PH3 , and PH4 ligands 
in CH2Cbat room temperature. 
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Figure 3.9  (a) Emission and (b) excitation spectra of PHI -Yb, PH2-Yb, PH3-Yb, and PH4-Yb 
complexes in CH2Cb ( 1 .6x I 0-6 M). The excitation wavelength was 3 75 nm. The emission 
wavelengths for PHI :  5 5 8  nm, PH2 : 574 nm, PH3 : 592 nm and PH4: 5 74 nm. 
1 . 1  
- PH l-Yb 
0.9 - PH2-Yb 
- PH3-Yb 
0.7 
> - PH4-Yb ... 





Figure 3.10 Normalized excitation spectra of ytterbium complexes at 980 nm in  CH2Cb at room 
temperature. 
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Formation of lanthanide complexes was confirmed by the emission in the NIR region. 
The NIR emission spectra of ligands are shown in Figure 3 . 1 1 .  The NIR emission of 
lanthanide ions is usually achieved by energy transfer from the ligand to the excited state 
of the lanthanide (Ill) ion. The PH I -Yb complex has the lowest NIR emission intensity 
while the PH4-Yb and PH2-Yb complexes have the highest NIR emission intensity in a 
similar level. The observed NIR emission pattern was PH4�PH2 > PH3 > PHI .  This 
observation suggests that the heavy atom effect of PH2 ligand is much stronger to 
sensitize the lanthanide ion than PH I ligand. Also, I -ethynyl-4-isothiocyanatobenzene 
electron withdrawing group in PH4 ligand can affect the sensitization process than the 4-
ethynylbenzoic acid group in PH3 ligand. All Yb(lll) complexes exhibited three peaks, 
centered at 975, I OO I ,  and 1 027 nm respectively. The intensity at l OO I  nm is stronger 
than the intensities at 980 and I 027 nm . They can be assigned to the transition between 
2Fs12 ground state and 2F711 2 excited state of Yb(lll) in BODIPY-bipyridine complex. 
The lifetime of ligands and complexes in visible and NIR regions are summarized in 
Table 3 .6 .  The visible region lifetimes were determined by excitation at 375 nm . The 
PHI ligand has a long lifetime (3 .67 ns) and PH2 ligand exhibited the lowest excited state 
lifetime of 2 .68 ns, which indicates the heavy atom effect. Ytterbium complexes have 
more or less similar life times to the ligands. The lifetimes of complexes in the NIR 
region were similar to each other ( 1 0 .9 µs - I 1 . I  µs) .  According to the quantum yield 
efficiencies, PHI ligand exhibited the highest quantum yield than other ligands (Table 
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Figure 3.1 1 NIR emission spectra of complexes in CH2Ch ( 1 .6 x 1 0-6 M) PHI -Yb A.ex = 530  nm, 
PH2-Yb Aex = 550  nm, PH3 -Yb Aex = 570 nm, Ph4-Yb Aex = 555  nm. 
Table 3.3 Photophysical properties (fluorescence) of ligands and BODIPY precursor, 
Fluorescence quantum yields of ligands were calculated by using rhodamine-6G excited at 480 
nm in EtOH as the reference quantum yield efficiency (0 = 0.95) 
Ligands Aex (run) Aem(run) 't (ns) (Visible Quantum yield 0 
region) in DCM 
PSOO l 502 5 1 5  3 . 52 0 .57±0 . 1 0  
PHI 533  570 3 .67 0 .468±0.02 
PH2 552 5 80 2 .68 0.209±0.0 1 
PH3 57 1  597 3 . 4 1  0 .3 1 8±0.04 
PH4 55 1 583  2 .96 0 . 1 1 3±0 .0 1  
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(Aex = 375 
run) 
558  977, 1 00 1 ,  
1 028 
574 978, 1 002, 
1 029 
592 975, 1 00 1 ,  
1 025 
574 975, 1 00 1 ,  
1 027 
t (ns) t (µs) Yb 0Yb 
(Visible (NIR 
region) region) 
3 .74 1 1 .0 0 .0048 
2 .73 1 1 . 1  0 .0048 
3 .3 7  1 1 .0 0 .0048 
2 .97 1 0 .9  0 .0047 
The ligand to metal ratio was investigated using spectrophotometric titration for all the 
ligands under the same conditions (Equation3 . l ) .  As an example, the titration of the PHl 
ligand with [Yb(hfac)3 · (H20)2] produces a gradual increase in the emission intensity in 
both UV-vis region and NIR region (Figure 3 . 1 2), and at saturation, the intensity is 
around 1 :  1 ratio between the ligand and Yb3+ ion. Also, the A.em of PH I ligand UV-Vis 
spectrum was gradually blue shifted (575 run to 562 run) with the complex formation. 
This pattern clearly was observed for all the ligands except for PH3 ligand in this study. 
One isosbestic point was observed for PHI (579 run), PH2 (625 run) and PH4 (637 run) 
ligands in UV-Vis spectra. The UV-Vis and NIR spectra of PH3 ligand were exhibited 
increasing of emission intensity at 595 run and 1 00 1  run in UV-Vis region and NIR 
region (Figure 3 . 1 3  ) .  These observations are significantly different from the studies that 
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have been done so far. Theoretically, UV-Vis emission should decrease with the NIR 
emission increase, due to the energy transfer process from the ligand to the ytterbium ion. 
However, in this study both UV-Vis and NIR emission increased for all four ligands. The 
bipyridine ligand binding group can quench the BODIPY fluorescence by donating 
electron to the BODIPY fluorophore using intersystem charge transfer process. 
Therefore, the BODIPY- bipyridine ligand emission intensity is comparatively lower than 
the actual fluorescence intensity. However, the electron donating process is gradually 
inhibited by the ytterbium complex formation, and fluorescence intensity is 
simultaneously increased with the Yb(III) complex formation. 
l igand Metal complex 
Equation 3.1 Metal complex formation using ligand and [Yb(hfac )3 " (H20)2] 
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Figure 3.12  (a) UV-Vis emission and (b) NIR emission spectral changes of PH l ligand upon 
addition of different amount of [Yb(hfac)J " (H20)2] in CH2Ch at room temperature. The 
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Figure 3.13 (a) UV-Vis emission and (b) NIR emission spectral changes of PH3 ligand upon 
addition of different amount of [Yb(hfac)3 · (H20)2] in CH2Cb at room temperature. The 




Currently, medical diagnosis probes have several drawbacks for improvement. One of 
those is the poor sensitivity of the diagnosis. The application of fluorescent probes inside 
living cells or biological tissues is a much more complicated process. The biological 
substrate fluorescence and diagnostic probes fluorescence are significantly overlapped, 
and it decreases the detection sensitivity.2 The fluorescence in the ultraviolet region and 
short wavelength of visible light ( <500 nm) causes some issues with the biological 
applications rather than long wavelength probes because it causes biological degradation 
of tissues and reduces the detection sensitivity of the measurements by overlapping with 
the autofluorescence of biological substrates .  Therefore, these probes should have some 
features to give a proper outcome in the biological sensing and imaging diagnosis 
process . One method for overcoming this problem is to shift the emission from the visible 
region to the near-infrared region. The NIR region does not only reduce the biological 
degradation but also increase the detection sensitivity. In addition, NIR light facilitates 
the in vivo tests due to the ability of deep penetration (up to 1 -2 cm in depth) of NIR 
light. 1 5  One strategy for shifting the absorbance towards these longer wavelength regions 
involves the extending conjugation of the sensitizer using attaching groups.  BODIPY 
molecules are especially responsive to this method. 
The BODIPY scaffold was used as the main skeleton because of its excellent chemical 
and photophysical properties and high tunable spectral coverage capability. Furthermore, 
the absorbance and emission spectra are highly influenced by the substituents added to 
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the BODIPY core. BODIPY dyes are photostable compared to many current dyes, and 
also their excited state lifetimes are relatively longer than other dyes. The primary goal of 
this research was to enhance the detection sensitivity by modifying the BODIPY 
molecule to make long absorption and emission wavelengths . In this study, we attempted 
to address each of these challenges by synthesizing novel BODIPY dyes with different 
substituents. Each of the designed dyes contained 5 -ethynyl-5 ' -methyl-2,2'-N-bipyridine 
group at C2 position of BODIPY core. The desired red-shifted absorbance was obtained 
by changing the C6position of BODIPY core using hydrogen (PHl ), iodine (PH2), 4-
ethynylbenzoic acid (PH3) and 1 -ethynyl-4-isothiocyanatobenzene (PH4) groups. 
Finally, a series of novel ytterbium (III) complexes were synthesized by using these 
ligands. 
After column chromatography purification, different yield parentages were obtained for 
further studies. The first synthetic step produced low and inconsistent yields. Several 
reaction conditions were attempted, including replacing TF A from boron trifluoride 
diethyl etherate as a catalyst, placing the reaction mixture in ice during the oxidative 
process with DDQ and use gravity filtration through silica gel to remove impurities .  
However, the yields remained around 29%. The iodination reaction was successful with 
high yields above 75% after column chromatography purification. The Sonogashira 
reactions were also successful but resulted in comparatively low yields below 40% after 
purification. 
The absorption spectra, emission spectra, and decay curves of synthesized compounds 
were obtained in CH2Ch at room temperature . The absorption spectra of ligands and 
complexes were very similar, and maximum absorption wavelengths increased from 537  
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run to 573 run in the ligands and 535  run to 57 1  run in their complexes. The absorption 
wavelengths were bathochromically shifted with the n-conjugated system of ligands. PH3 
ligand has the longest absorption wavelength compare with the other ligands. The Yb(III) 
complexes exhibited three peaks centered at 975 run, 1 00 1  run, and 1 027 run, 
respectively. The lifetimes (NIR region) of the Yb(III) complexes ( 1 0 .9  - 1 1 . 1  µs) were 
mostly similar, which gave the emission yield 0 .09%. The PHl has the highest 
fluorescence quantum yield efficiency (0 = 0.478) and the PH4 ligand has the lowest 
quantum yield efficiency compared with the other two ligands. PH2 also has low 
quantum yield than PHl ligand because of the heavy atom iodine significantly quenches 
its fluorescence. This data illustrated that the NIR emission efficiency decreases in the 
order PH4 :::::: PH2 > PH3> PHl .  The spectrophotometric titration data confirmed the 1 : 1  
ratio of ligand: [Yb(hfac)J " (H20)z] metal complex. The intensities of both visible and 
NIR spectra intensity were increased with the Yb(III) concentration, indicating the low 
efficiency of sensitization by BODIPY-bipyridine ligands. The sensitization process can 
be inhibited by intermolecular charge transfer process between bipyridine unit and 
BODIPY core because bipyridine group can facilitate the back charge transfer process. 
Therefore, this main disadvantage of bipyridine ligand binding group is significantly 
affected by the sensitization process. However, further improvement of the ligand design 
has to be implemented to increase the energy-transfer efficiency in NIR region. Future 
work include the investigation of highly efficient energy transfer ligand using 1 ,  1 0-
phenanthroline ligand binding group by replacing bipyridine ligand. 
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APPENDIX 
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observed [/ > 2cr(D] reflections 
Rint 
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Refinement 




�Pmax, �Pmin (e A-3) 
Bruker APEXII CCD 
Multi-scan 
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0 . 1 08 
0 .602 
0 .066, 0 . 1 86, 0 .99 
305 1 
222 
H-atom parameters constrained 
0 . 1 9, -0 .36 
Computer progra ms:  SHELXL2014/7 (Sheld rick, 2014) . 
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No. of measured, independent and 
observed [/ > 2cr(D] reflections 
(sin 8/A)max (A-1) 
Refinement 
R[F2 > 2cr(F2)] , wR(F2), S 
No. of reflections 
No. of parameters 
No. of restraints 
H-atom treatment 
Bruker APEXII CCD 
Multi-scan 
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0 . 1 50 
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H-atom parameters constrained 
w = l /fcr2(F02) + (0.044 1 P)2 + 1 6 .4545Pl 
where P = (Fo2 + 2Fc2)/3 
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